Section 12

EurekaMag Full Text Articles Chapter 11,979


Grothues, M.; Traeder, W.; Ott, M. 2005: Draxxin (R) des erste triamilid, ein jahr im praxistest. Tieraerztliche Umschau 60(7): 382-389
Cipolli, C.; Bonanni, E.; Maestri, M.; Mazzetti, M.; Murri, L. 2004: Dream experience during REM and NREM sleep of patients with complex partial seizures. Brain Research Bulletin 63(5): 407-413
Aoki, C.; Sekino, Y.; Hanamura, K.; Fujisawa, S.; Mahadomrongkul, V.; Ren, Y.; Shirao, T. 2005: Drebrin a is a postsynaptic protein that localizes in vivo to the submembranous surface of dendritic sites forming excitatory synapses. Journal of Comparative Neurology 483(4): 383-402
Chew, C.S.; Okamoto, C.T.; Chen, X.; Thomas, R. 2005: Drebrin E2 is differentially expressed and phosphorylated in parietal cells in the gastric mucosa. American Journal of Physiology. Gastrointestinal and Liver Physiology 289(2): G320-G331
Butkevich, E.; Hülsmann, S.; Wenzel, D.; Shirao, T.; Duden, R.; Majoul, I. 2004: Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton. Current Biology: Cb 14(8): 650-658
Peitsch, W.K.; Hofmann, I.; Bulkescher, J.; Hergt, M.; Spring, H.; Bleyl, U.; Goerdt, S.; Franke, W.W. 2005: Drebrin, an actin-binding, cell-type characteristic protein: induction and localization in epithelial skin tumors and cultured keratinocytes. Journal of Investigative Dermatology 125(4): 761-774
Yu, Z.; Zhang, Y.; Qiao, M.; Baral, H. , O.; Weber, E.; Zhang, K. 2006: Drechslerella brochopaga, the anamorph of Orbilia (Hyalinia) orientalis. Mycotaxon 96: 163-168
Itoh, T.; Onitsuka, T.; Maruyama, T. 2005: Dredged juveniles of the freshwater unionid mussel Pronodularia japanensis (Unionidae) in Tochigi Prefecture, Japan. Chiribotan 36(3): 67-69
Froehner, S.E. 2001: Drei neue Alchemilla-Endemiten (Rosaceae) aus den osterreichischen Alpen. Neilreichia 1: 21-30
Litterski, B.; Adler, A.; Joerns, S. 2006: Dreifelderwirtschaft - Chance fur den Segetalartenschutz auf ertragsschwachen Standorten. Tuexenia 26: 297-310
Hubenov, Z. 2005: Dreissena (Bivalvia: Dreissenidae) - Systematics, autochthonous and anthropogenic areas. Acta Zoologica Bulgarica 57(3): 259-268
Orlova, M.; Golubkov, S.; Kalinina, L.; Ignatieva, N. 2004: Dreissena polymorpha (Bivalvia: Dreissenidae) in the Neva Estuary (eastern Gulf of Finland, Baltic Sea): is it a biofilter or source for pollution?. Marine Pollution Bulletin 49(3): 196-205
Beraudo, M.; Chau, O.; Tinghitella, G.; Chiurco, L.; Astiz, L.; Manuel-Astiz, J. 2006: Drenaje percutaneo guiado de abscesos abdominales. Prensa Medica Argentina 93(4): 228-233
Fuertes, E.; Olivan, G.; Acon, M. 2004: Drepanocladus (Amblystegiaceae, Bryopsida) in the Iberian Peninsula. Belgian Journal of Botany 136(2): 167-173
Nadkarni, S.; Jung, P. 2005: Dressed neurons: modeling neural-glial interactions. Physical Biology 1(1-2): 35-41
Campbell, B.G. 2006: Dressings, bandages, and splints for wound management in dogs and cats. Veterinary Clinics of North America. Small Animal Practice 36(4): 759-791
Kibar, Y.; Avci, A.; Akay, O.; Dayanç, M. 2005: Dribbling of urine due to ectopic vaginal insertion of an upper pole ureter diagnosed by magnetic resonance urography. International Urology and Nephrology 37(4): 695-697
Aburuz, S.; Millership, J.; McElnay, J. 2006: Dried blood spot liquid chromatography assay for therapeutic drug monitoring of metformin. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 832(2): 202-207
Toledo, A.Carlos.de.Castro.; Januário, Jé.Nélio.; Rezende, R.Maria.Silva.; Siqueira, A.Lúcia.; Mello, B.Freire.de.; Fialho, E.Ligorio.; Ribeiro, R.Andrade.; Silva, Hélia.Lemos.da.; Pires, E.Carvalho.; Simões, Tá.César.; Greco, D.Bartolomeu. 2005: Dried blood spots as a practical and inexpensive source for human immunodeficiency virus and hepatitis C virus surveillance. Memorias do Instituto Oswaldo Cruz 100(4): 365-370
Hooda, S.; Tyagi, P.K. 2003: Dried goat waste: An egg yolk colourant for laying hens. Indian Journal of Poultry Science 38(3): 281-284
Ros, A.; Montes-Moran, M.A.; Fuente, E.; Nevskaia, D.M.; Martin, M.J. 2006: Dried sludges and sludge-based chars for H2S removal at low temperature: influence of sewage sludge characteristics. Environmental Science and Technology 40(1): 302-309
Westropp, J.L.; Ruby, A.L.; Bailiff, N.L.; Kyles, A.E.; Ling, G.V. 2006: Dried solidified blood calculi in the urinary tract of cats. Journal of Veterinary Internal Medicine 20(4): 828-834
Yang, L.; Sturgeon, R., E.; Mester, Z. 2005: Dried-droplet laser ablation ICP-MS of HPLC fractions for the determination of selenomethionine in yeast. Journal of Analytical Atomic Spectrometry 20(5): 431-435
Cereghino, R.; Legalle, M.; Lavandier, P. 2004: Drift and benthic population structure of the mayfly Rhithrogena semicolorata (Heptageniidae) under natural and hydropeaking conditions. Hydrobiologia 519(1-3): 127-133
Shapiro, J.L. 2005: Drift and scaling in estimation of distribution algorithms. Evolutionary Computation 13(1): 99-123
Shimada, K.; Urabe, M. 2004: Drift and upstream movement of Semisulcospira libertina (Caenogastropoda: Pleuroceridae) in a natural stream. Venus 63(1-2): 49-59
Robinson, C.T.; Tockner, K.; Burgherr, P. 2004: Drift benthos relationships in the seasonal colonization dynamics of alpine streams. Archiv fur Hydrobiologie 160(4): 447-470
Page, B.; Mckenzie, J.; Hindell, M., A.; Goldsworthy, S., D. 2005: Drift dives by male New Zealand fur seals (Arctocephalus forsteri). Canadian Journal of Zoology 83(2): 293-300
Carlsen, S.C.K.; Spliid, N.H.; Svensmark, B. 2006: Drift of 10 herbicides after tractor spray application. 1. Secondary drift (evaporation). Chemosphere 64(5): 787-794
Carlsen, S.C.K.; Spliid, N.H.; Svensmark, B. 2006: Drift of 10 herbicides after tractor spray application. 2. Primary drift (droplet drift). Chemosphere 64(5): 778-786
Peterka, J.; Vasek, M.; Kubecka, J.; Hladik, M.; Hohausova, E. 2004: Drift of juveniles after riverine spawning of fishes from the Rimov reservoir, Czech Republic. Ecohydrology and Hydrobiology 4(4): 459-468
Norton, D., W.; Gaylord, A.-Graves 2004: Drift velocities of ice floes in Alaska's northern Chukchi sea flaw zone: Determinants of success by spring subsistence whalers in 2000 and 2001. Arctic 57(4): 347-362
Dahms, H.U.; Qian, P.Y.an 2004: Drift-pump and drift-net-two devices for the collection of bottom-near drifting biota. Journal of Experimental: 29-37
Ikehara, K.; Hayashida, F. 2003: Drifted seaweed on a Miho beach in the innermost part of Suruga Bay, central Japan. Journal of the School of Marine Science and Technology Tokai University 1(1): 31-37
Lima, E.-Moura; Rissino, J.-Dores; Guimaraes, A.-Costa; Overal, D.-James; Khayat, A.-Salim; De-Souza, P.-Carvalho; Christofolani, D.-Maria; Smith, M.-De-Arruda-Cardoso; Burbano, R.-Rodriguez 2005: Drifter technique: A new method to obtain metaphases in Hep-2 cell line cultures. Brazilian Archives of Biology and Technology 48(4): 537-540
Arroyo, N.-Larissa; Aarnio, K.; Bonsdorff, E. 2006: Drifting algae as a means of re-colonizing defaunated sediments in the Baltic Sea. A short-term microcosm study. Hydrobiologia 554: 83-95
Cadee, G.C. 2005: Drifting branches of Crambe maritima L. with fruits. Cahiers de Biologie Marine 46(2): 217-219
Dempster, T.; Kingsford, M.J. 2004: Drifting objects as habitat for pelagic juvenile fish off New South Wales, Australia. ine and Freshwater Research 55(7): 675-687
Downes, B.J.; Bellgrove, A.; Street, J.L. 2005: Drifting or walking? Colonisation routes used by different instars and species of lotic, macroinvertebrate filter feeders. ine and Freshwater Research 56(6): 815-824
Barnes, D.; Milner, P. 2005: Drifting plastic and its consequences for sessile organism dispersal in the Atlantic Ocean. ine Biology Berlin ch; 146(4): 815-825
Breuer, E.; Stevenson, A.G.; Howe, J.A.; Carroll, J.; Shimmield, G.B. 2004: Drill cutting accumulations in the Northern and Central North Sea: a review of environmental interactions and chemical fate. Marine Pollution Bulletin 48(1-2): 12-25
Nweke, C.O.; Okpokwasili, G.C. 2003: Drilling fluid base oil biodegradation potential of a soil Staphylococcus species. African Journal of Biotechnology 2(9): 293-295
Delance, J.-Henri; Emig, C., C. 2004: Drilling predation on Gryphus vitreus (Brachiopoda) off the French Mediterranean coasts. Palaeogeography Palaeoclimatology Palaeoecology 208(1-2): 23-30
Hoffmeister, A.P.; Kowalewski, M.; Baumiller, T.K.; Bambach, R.K. 2004: Drilling predation on Permian brachiopods and bivalves from the Glass Mountains, west Texas. Acta Palaeontologica Polonica y; 49(3): 443-454
Brink, E.; Dold, A.P. 2003: Drimia acarophylla (Hyacinthaceae), a new species from Eastern Cape, South Africa. South African Journal of Botany 69(3): 396-400
Dold, A.P.; Brink, E. 2004: Drimia chalumnensis (Hyacinthaceae - Urgineoideae), a new species from Eastern Cape, South Africa. South African Journal of Botany 70(4): 631-634
Edwards, T.J.; Crouch, N.R.; Styles, D. 2005: Drimia flagellaris (Hyacinthaceae): a new discovery from KwaZulu-Natal. South African Journal of Botany 71(1): 122-126
Smit, H.; Gerling, T.; De-Boer, J. 2005: Dringlichkeit, erfoigsaussicht, chancengleichheit - Grundlagen und verteilungspraxis postmortal gespendeter organe in Deutschland. Intensivmedizin und Notfallmedizin 42(6): 489-495
Tay, R. 2005: Drink driving enforcement and publicity campaigns: are the policy recommendations sensitive to model specification?. Accident; Analysis and Prevention 37(2): 259-266
Mündel, T.; King, J.; Collacott, E.; Jones, D.A. 2006: Drink temperature influences fluid intake and endurance capacity in men during exercise in a hot, dry environment. Experimental Physiology 91(5): 925-933
Hjelland, I.E.; Ofstad, A.P.; Narvestad, J.K.; Berstad, A.; Hausken, T. 2004: Drink tests in functional dyspepsia: which drink is best?. Scandinavian Journal of Gastroenterology 39(10): 933-937
Greenberg, M.D.; Morral, A.R.; Jain, A.K. 2005: Drink-driving and DUI recidivists' attitudes and beliefs: a longitudinal analysis. Journal of Studies on Alcohol 66(5): 640-647
Norbury, C.C. 2006: Drinking a lot is good for dendritic cells. Immunology 117(4): 443-451
Varsamos, S.; Bonga, S.W.; Charmantier, G.; Flik, G. 2004: Drinking and Na+/K+ ATPase activity during early development of European sea bass, Dicentrarchus labrax - Ontogeny and short-term regulation following acute salinity changes. Journal of Experimental: 189-200
Sekii, T.; Shimizu, S.; So, T. 2005: Drinking and domestic violence: findings from clinical survey of alcoholics. Nihon Arukoru Yakubutsu Igakkai Zasshi 40(2): 95-104
Wechsler, H.; Lee, J.Eun.; Nelson, T.F.; Lee, H. 2003: Drinking and driving among college students: the influence of alcohol-control policies. American Journal of Preventive Medicine 25(3): 212-218
Chalder, M.; Elgar, F.J.; Bennett, P. 2005: Drinking and motivations to drink among adolescent children of parents with alcohol problems. Alcohol and Alcoholism 41(1): 107-113
Bell, N.S.; Harford, T.; McCarroll, J.E.; Senier, L. 2004: Drinking and spouse abuse among U.S. Army soldiers. Alcoholism Clinical and Experimental Research 28(12): 1890-1897
Bingham, C.Raymond.; Shope, J.T.; Tang, X. 2005: Drinking behavior from high school to young adulthood: differences by college education. Alcoholism Clinical and Experimental Research 29(12): 2170-2180
Mukamal, K.J.; Jensen, M.K.; Grønbaek, M.; Stampfer, M.J.; Manson, J.E.; Pischon, T.; Rimm, E.B. 2005: Drinking frequency, mediating biomarkers, and risk of myocardial infarction in women and men. Circulation 112(10): 1406-1413
Zamboanga, B.L.; Leitkowski, L.K.; Rodríguez, L.; Cascio, K.A. 2006: Drinking games in female college students: more than just a game?. Addictive behaviors 31(8): 1485-1489
Chen, L.-H.; Baker, S.P.; Li, G. 2005: Drinking history and risk of fatal injury: comparison among specific injury causes. Accident; Analysis and Prevention 37(2): 245-251
Petzel, D. 2005: Drinking in Antarctic fishes. Polar Biology ober; 28(10): 763-768
Beirness, D.J.; Foss, R.D.; Vogel-Sprott, M. 2004: Drinking on campus: self-reports and breath tests. Journal of Studies on Alcohol 65(5): 600-604
Giesbrecht, N.; Ialomiteanu, A.; Anglin, L. 2005: Drinking patterns and perspectives on alcohol policy: results from two Ontario surveys. Alcohol and Alcoholism 40(2): 132-139
Cherpitel, C.J.; Moskalewicz, J.; Swiatkiewicz, G. 2004: Drinking patterns and problems in emergency services in Poland. Alcohol and Alcoholism 39(3): 256-261
Breslow, R.A.; Smothers, B. 2004: Drinking patterns of older Americans: National Health Interview Surveys, 1997-2001. Journal of Studies on Alcohol 65(2): 232-240
Wells, S.; Graham, K.; Speechley, M.; Koval, J.J. 2005: Drinking patterns, drinking contexts and alcohol-related aggression among late adolescent and young adult drinkers. Addiction 100(7): 933-944
Shimizu, S.; Kim, D.Soo.; Hirota, M. 2004: Drinking practice and alcohol-related problems: the national representative sample survey for Healthy Japan 21. Nihon Arukoru Yakubutsu Igakkai Zasshi 39(3): 189-206
Oei, T.P.S.; Hasking, P.A.; Young, R.McD. 2005: Drinking refusal self-efficacy questionnaire-revised (DRSEQ-R): a new factor structure with confirmatory factor analysis. Drug and Alcohol Dependence 78(3): 297-307
Trim, R.S.; Chassin, L. 2004: Drinking restraint, alcohol consumption and alcohol dependence among children of alcoholics. Journal of Studies on Alcohol 65(1): 122-125
Voas, R.B.; Romano, E.; Tippetts, A.Scott.; Furr-Holden, C.Debra.M. 2006: Drinking status and fatal crashes: which drinkers contribute most to the problem?. Journal of Studies on Alcohol 67(5): 722-729
Thomas, S.E.; Randall, C.L.; Carrigan, M.H. 2003: Drinking to cope in socially anxious individuals: a controlled study. Alcoholism Clinical and Experimental Research 27(12): 1937-1943
Todd, M.; Armeli, S.; Tennen, H.; Carney, M.Anne.; Ball, S.A.; Kranzler, H.R.; Affleck, G. 2005: Drinking to cope: a comparison of questionnaire and electronic diary reports. Journal of Studies on Alcohol 66(1): 121-129
Ward, M.H.; Heineman, E.F.; McComb, R.D.; Weisenburger, D.D. 2005: Drinking water and dietary sources of nitrate and nitrite and risk of glioma. Journal of Occupational and Environmental Medicine 47(12): 1260-1267
Sobsey, M.D. 2006: Drinking water and health research: a look to the future in the United States and globally. Journal of Water and Health 4(Suppl): 17-21
Simões, L.C.; Azevedo, N.; Pacheco, A.; Keevil, C.W.; Vieira, M.J. 2006: Drinking water biofilm assessment of total and culturable bacteria under different operating conditions. Biofouling 22(1-2): 91-99
Yang, C.-Y. 2004: Drinking water chlorination and adverse birth outcomes in Taiwan. Toxicology 198(1-3): 249-254
Infante-Rivard, C. 2004: Drinking water contaminants, gene polymorphisms, and fetal growth. Environmental Health Perspectives 112(11): 1213-1216
Rainey, R.C.; Harding, A.K. 2005: Drinking water quality and solar disinfection: effectiveness in peri-urban households in Nepal. Journal of Water and Health 3(3): 239-248
Caetano, R.; McGrath, C.; Ramisetty-Mikler, S.; Field, C.A. 2005: Drinking, alcohol problems and the five-year recurrence and incidence of male to female and female to male partner violence. Alcoholism Clinical and Experimental Research 29(1): 98-106
Leonard, K.E.; Quigley, B.M.; Collins, R.Lorraine. 2003: Drinking, personality, and bar environmental characteristics as predictors of involvement in barroom aggression. Addictive Behaviors 28(9): 1681-1700
Fewtrell, L. 2004: Drinking-water nitrate, methemoglobinemia, and global burden of disease: a discussion. Environmental Health Perspectives 112(14): 1371-1374
Stringfellow, W.T.; Komada, T.; Chang, L-Yang. 2006: Drip-feed bioreactor for the treatment of concentrated wastes with minimal dilution. Chemosphere 65(1): 141-147
Purcell, K.; Fergie, J. 2004: Driscoll Children's Hospital respiratory syncytial virus database: risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatric Infectious Disease Journal 23(5): 418-423
Gany, F.M.; Trinh-Shevrin, C.; Changrani, J. 2005: Drive-by readings: a creative strategy for tuberculosis control among immigrants. American journal of public health 95(1): 117-119
Yannis, G.; Golias, J.; Papadimitriou, E. 2005: Driver age and vehicle engine size effects on fault and severity in young motorcyclists accidents. Accident; Analysis and Prevention 37(2): 327-333
Horberry, T.; Anderson, J.; Regan, M.A.; Triggs, T.J.; Brown, J. 2006: Driver distraction: the effects of concurrent in-vehicle tasks, road environment complexity and age on driving performance. Accident; Analysis and Prevention 38(1): 185-191
Sagberg, F. 2006: Driver health and crash involvement: a case-control study. Accident; Analysis and Prevention 38(1): 28-34
Uc, E.Y.; Rizzo, M.; Anderson, S.W.; Shi, Q.; Dawson, J.D. 2005: Driver landmark and traffic sign identification in early Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry 76(6): 764-768
Hamilton, W.I.; Clarke, T. 2005: Driver performance modelling and its practical application to railway safety. Applied Ergonomics 36(6): 661-670
Uc, E.Y.; Rizzo, M.; Anderson, S.W.; Shi, Q.; Dawson, J.D. 2004: Driver route-following and safety errors in early Alzheimer disease. Neurology 63(5): 832-837
Liu, G-Fen.; Han, S.; Liang, D-Hong.; Wang, F-Zhi.; Shi, X-Zhu.; Yu, J.; Wu, Z-Lai. 2003: Driver sleepiness and risk of car crashes in Shenyang, a Chinese northeastern city: population-based case-control study. Biomedical and Environmental Sciences: Bes 16(3): 219-226
Stutts, J.; Feaganes, J.; Reinfurt, D.; Rodgman, E.; Hamlett, C.; Gish, K.; Staplin, L. 2005: Driver's exposure to distractions in their natural driving environment. Accident; Analysis and Prevention 37(6): 1093-1101
Shabsigh, R.; Perelman, M.A.; Laumann, E.O.; Lockhart, D.C. 2004: Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries. Bju International 94(7): 1055-1065
Dummett, K. 2006: Drivers for corporate environmental responsibility (CER). Environment Development and Sustainability 8(3): 375-389
Kleindorfer, P.R.; Elliott, M.R.; Wang, Y.; Lowe, R.A. 2004: Drivers of accident preparedness and safety: evidence from the RMP Rule. Journal of Hazardous Materials 115(1-3): 9-16
Rogers, S., D.; Kadar, E., E.; Costall, A. 2005: Drivers' gaze patterns in braking from three different approaches to a crash barrier. Ecological Psychology 17(1): 39-53
Sordella, R.; Van Aelst, L. 2006: Driving actin dynamics under the influence of alcohol. Cell 127(1): 37-39
Kostyniuk, L.P.; Shope, J.T. 2003: Driving and alternatives: older drivers in Michigan. Journal of Safety Research 34(4): 407-414
Stewart, A.E.; St Peter, C.C. 2004: Driving and riding avoidance following motor vehicle crashes in a non-clinical sample: psychometric properties of a new measure. Behaviour Research and Therapy 42(8): 859-879
Dahlen, E.R.; Martin, R.C.; Ragan, K.; Kuhlman, M.M. 2005: Driving anger, sensation seeking, impulsiveness, and boredom proneness in the prediction of unsafe driving. Accident; Analysis and Prevention 37(2): 341-348
Macdonald, S.; DeSouza, A.; Mann, R.; Chipman, M. 2004: Driving behavior of alcohol, cannabis, and cocaine abuse treatment clients and population controls. American Journal of Drug and Alcohol Abuse 30(2): 429-444
Barsh, R.L.; Marlor, C. 2003: Driving bison and Blackfoot science. Human Ecology 31(4): 571-593
Talbot, A.; Bruce, I.; Cunningham, C.J.; Coen, R.F.; Lawlor, B.A.; Coakley, D.; Walsh, J.B.; O'Neill, D. 2005: Driving cessation in patients attending a memory clinic. Age and Ageing 34(4): 363-368
Santos, M.A.S.; Moura, G.; Massey, S.E.; Tuite, M.F. 2004: Driving change: the evolution of alternative genetic codes. Trends in Genetics: Tig 20(2): 95-102
Cohen, H.S.; Wells, J.; Kimball, K.T.; Owsley, C. 2003: Driving disability and dizziness. Journal of Safety Research 34(4): 361-369
Strauss, K.; MacLean, C.; Troy, A.; Littenberg, B. 2006: Driving distance as a barrier to glycemic control in diabetes. Journal of General Internal Medicine 21(4): 378-380
Khandelia, H.; Langham, A.A.; Kaznessis, Y.N. 2006: Driving engineering of novel antimicrobial peptides from simulations of peptide-micelle interactions. Biochimica et Biophysica Acta 1758(9): 1224-1234
Perlovich, G.L.; Skar, M.; Bauer-Brandl, A. 2003: Driving forces and the influence of the buffer composition on the complexation reaction between ibuprofen and HPCD. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 20(2): 197-200
Neirynck, J.; Kowalski, A.S.; Carrara, A.; Ceulemans, R. 2005: Driving forces for ammonia fluxes over mixed forest subjected to high deposition loads. Atmospheric Environment 39(28): 5013-5024
Olofsson, M.; Sahlin, J.; Ekvall, T.; Sundberg, J. 2005: Driving forces for import of waste for energy recovery in Sweden. Waste Management and Research: the Journal of the International Solid Wastes and Public Cleansing Association Iswa 23(1): 3-12
Mulder, C. 2006: Driving forces from soil invertebrates to ecosystem functioning: the allometric perspective. Die Naturwissenschaften 93(10): 467-479
Burgi, M.; Hersperger, A.M.; Schneeberger, N. 2004: Driving forces of landscape change - current and new directions. Landscape Ecology 19(8): 857-868
Familoni, B.O.; Abell, T.L.; Gan, Z.; Voeller, G. 2005: Driving gastric electrical activity with electrical stimulation. Annals of Biomedical Engineering 33(3): 356-364
Anonymous 2006: Driving geckos up the wall. Journal of Experimental Biology 209(2): I
Wingen, M.; Ramaekers, J.G.; Schmitt, J.A.J. 2006: Driving impairment in depressed patients receiving long-term antidepressant treatment. Psychopharmacology 188(1): 84-91
Schrag, A. 2005: Driving in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 76(2): 159
Homann, C.N.; Suppan, K.; Homann, B.; Crevenna, R.; Ivanic, G.; Ruzicka, E. 2003: Driving in Parkinson's disease - a health hazard?. Journal of Neurology 250(12): 1439-1446
Foley, D.J.; Heimovitz, H.K.; Guralnik, J.M.; Brock, D.B. 2002: Driving life expectancy of persons aged 70 years and older in the United States. American Journal of Public Health 92(8): 1284-1289
Wouters, K.L.; de Tacconi, N.R.; Konduri, R.; Lezna, R.O.; MacDonnell, F.M. 2006: Driving multi-electron reactions with photons: dinuclear ruthenium complexes capable of stepwise and concerted multi-electron reduction. Photosynthesis Research 87(1): 41-55
Lesch, M.F.; Hancock, P.A. 2004: Driving performance during concurrent cell-phone use: are drivers aware of their performance decrements?. Accident; Analysis and Prevention 36(3): 471-480
Daanen, H.A.M.; van de Vliert, E.; Huang, X. 2003: Driving performance in cold, warm, and thermoneutral environments. Applied Ergonomics 34(6): 597-602
Cranney, A.B.; Harrison, A.; Ruhland, L.; Vaidyanath, C.; Graham, I.; Man-Son-Hing, M.; Jaffey, J.; Towheed, T.E.; Anastassiades, T.P.; Dwosh, I.I. 2005: Driving problems in patients with rheumatoid arthritis. Journal of Rheumatology 32(12): 2337-2342
Freeman, E.E.; Gange, S.J.; Muñoz, B.; West, S.K. 2006: Driving status and risk of entry into long-term care in older adults. American Journal of Public Health 96(7): 1254-1259
Caetano, R.; McGrath, C. 2005: Driving under the influence (DUI) among U.S. ethnic groups. Accident; Analysis and Prevention 37(2): 217-224
Jones, A.W. 2005: Driving under the influence of chlormethiazole. Forensic Science International 153(2-3): 213-217
Toennes, S.W.; Kauert, G.F.; Steinmeyer, S.; Moeller, M.R. 2005: Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Science International 152(2-3): 149-155
Leon-Carrion, J.; Dominguez-Morales, M.R.; Martin, J.M.Barroso.Y. 2005: Driving with cognitive deficits: neurorehabilitation and legal measures are needed for driving again after severe traumatic brain injury. Brain Injury 19(3): 213-219
Bardot, B.; Lecoin, L.; Fliniaux, I.; Huillard, E.; Marx, M.; Viallet, J.P. 2004: Drm/Gremlin, a BMP antagonist, defines the interbud region during feather development. International Journal of Developmental Biology 48(2-3): 149-156
Danek, J. 2005: Drobnoustroje w nasieniu ogierow. Medycyna Weterynaryjna 61(4): 387-390
Iwersen-Bergmann, S.; Stein, S.; Schmoldt, A. 2004: Drogen and Medikamente bei Strassenverkehrsteilnehmern in Hamburg von 1993-2000. Blutalkohol 41(6): 493-506
Schuetz, H.; Pain, A.; Erdmann, F.; Verhoff, M., A.; Weiler, G. 2006: Drogenscreening im harn - haufige fehlerquellen bei der messung und interpretation. Archiv fuer Kriminologie 217(1-2): 1-9
Raby, W.Noël.; Modica, P.A.; Wolintz, R.J.; Murtaugh, K. 2006: Dronabinol reduces signs and symptoms of idiopathic intracranial hypertension: a case report. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 22(1): 68-75
Oyetayo, O.O.; Rogers, C.E.; Hofmann, P.O. 2010: Dronedarone: a new antiarrhythmic agent. PharmacoTherapy 30(9): 904-915
Wegener, F.T.; Ehrlich, J.R.; Hohnloser, S.H. 2006: Dronedarone: an emerging agent with rhythm- and rate-controlling effects. Journal of Cardiovascular Electrophysiology 17(Suppl): S17-S20
Van der Burg, J.J.W.; Jongerius, P.H.; Van Hulst, K.; Van Limbeek, J.; Rotteveel, J.J. 2006: Drooling in children with cerebral palsy: effect of salivary flow reduction on daily life and care. Developmental Medicine and Child Neurology 48(2): 103-107
Meningaud, J.-P.; Pitak-Arnnop, P.; Chikhani, L.; Bertrand, J.-C. 2006: Drooling of saliva: a review of the etiology and management options. Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics 101(1): 48-57
Lee, H.; Yi, H.-A.; Lee, S.-R.; Ahn, B.-H.; Park, B.-R. 2005: Drop attacks in elderly patients secondary to otologic causes with Meniere's syndrome or non-Meniere peripheral vestibulopathy. Journal of the Neurological Sciences 232(1-2): 71-76
Boddaert, J.; Verny, M. 2005: Drop attacks in older adults: systematic assessment has a high diagnostic yield. Psychologie and Neuropsychiatrie du Vieillissement 3(2): 137-138
Brantberg, K.; Ishiyama, A.; Baloh, R.W. 2005: Drop attacks secondary to superior canal dehiscence syndrome. Neurology 64(12): 2126-2128
Luo, G.S.; Li, H.B.; Tang, X.J.; Wang, J.D. 2004: Drop breakage in a coalescence-dispersion pulsed-sieve-plate extraction column. Chemical Engineering Journal 102(2): 185-191
Barhate, R.S.; Patil, G.; Srinivas, N.D.; Raghavarao, K.S.M.S. 2004: Drop formation in aqueous two-phase systems. Journal of Chromatography A 1023(2): 197-206
Del Monte, U.; Statuto, M. 2004: Drop of connexins: a possible link between aging and cancer?. Experimental Gerontology 39(2): 273-275
Sugiyama, M.; Koimaru, H.; Shiba, M.; Ono, E.; Nagata, T.; Ito, T. 2006: Drop of egg production in chickens by experimental infection with an avian metapneumovirus strain PLE8T1 derived from swollen head syndrome and the application to evaluate vaccine. Journal of Veterinary Medical Science 68(8): 783-787
Alexander, A.; Subramanian, N.; Buxbaum, J.N.; Jacobson, D.R. 2004: Drop-in, drop-out allele-specific PCR: a highly sensitive, single-tube method. Molecular Biotechnology 28(3): 171-174
Eberhart, L.H.J.; Morin, A.M.; Hoerle, S.; Wulf, H.; Geldner, Götz. 2004: Droperidol and dolasetron alone or in combination for prevention of postoperative nausea and vomiting after vitrectomy. Ophthalmology 111(8): 1569-1575
Shiga, T.; Yong, S.; Carino, J.; Murray, P., A.; Damron, D., S. 2005: Droperidol inhibits fits intracellular Ca2+ myofilament Ca2+ sensitivity, and contraction in rat ventricular myocytes. Anesthesiology (Hagerstown) 102(6): 1165-1173
Chabert, M.; Dorfman, K.D.; Viovy, J.-L. 2005: Droplet fusion by alternating current (AC) field electrocoalescence in microchannels. Electrophoresis 26(19): 3706-3715
Stainier, C.D.stain, M.; Schiffers, B.L.beau, F. 2006: Droplet size spectra and drift effect of two phenmedipham formulations and four adjuvants mixtures. Crop protection 25(12): 1238-1243
Schwartz, J.A.; Vykoukal, J.V.; Gascoyne, P.R.C. 2004: Droplet-based chemistry on a programmable micro-chip. Lab on a Chip 4(1): 11-17
Srinivasan, V.; Pamula, V.K.; Fair, R.B. 2004: Droplet-based microfluidic lab-on-a-chip for glucose detection. Analytica Chimica Acta 507(1): 145-150
Kemmler, G.; Hummer, M.; Widschwendter, C.; Fleischhacker, W.Wolfgang. 2005: Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis. Archives of General Psychiatry 62(12): 1305-1312
Pelagotti, F.; Santarlasci, B.; Vacca, F.; Trippoli, S.; Messori, A. 2004: Dropout rates with olanzapine or risperidone: a multi-centre observational study. European Journal of Clinical Pharmacology 59(12): 905-909
Roberts, D.J.; Chun, H.M. 2005: Dropped gallstone as a nidus of intra-abdominal abscess complicated by empyema. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 41(6): E64-E66
Yanmiş, I.; Tunay, S.; Oğuz, E.; Yildiz, C.; Ozkan, H.üs.; Kirdemir, V. 2004: Dropping of an EndoButton into the knee joint 2 years after anterior cruciate ligament repair using proximal fixation methods. Arthroscopy: the Journal of Arthroscopic and Related Surgery: Official Publication of the Arthroscopy Association of North America and the International Arthroscopy Association 20(6): 641-643
DeSoto, M.Catherine. 2003: Drops in estrogen levels affect brain, body and behavior: reported relationship between attitudes and menopausal symptoms. Maturitas 45(4): 299-301
Tarlao, A.; Tunis, G.; Venturini, S. 2005: Dropstones, pseudoplanktonic forms and deep-water decapod crustaceans within a Lutetian condensed succession of central Istria (Croatia): relation to palaeoenvironmental evolution and palaeogeography. Palaeogeography Palaeoclimatology Palaeoecology 218(3-4): 325-345
Bi, X.; Srikanta, D.; Fanti, L.; Pimpinelli, S.; Badugu, R.; Kellum, R.; Rong, Y.S. 2005: Drosophila ATM and ATR checkpoint kinases control partially redundant pathways for telomere maintenance. Proceedings of the National Academy of Sciences of the United States of America 102(42): 15167-15172
Bi, X.; Gong, M.; Srikanta, D.; Rong, Y.S. 2005: Drosophila ATM and Mre11 are essential for the G2/M checkpoint induced by low-dose irradiation. Genetics 171(2): 845-847
Qi, D.; Larsson, J.; Mannervik, M. 2004: Drosophila Ada2b is required for viability and normal histone H3 acetylation. Molecular and Cellular Biology 24(18): 8080-8089
Möller, A.é; Avila, F.W.; Erickson, J.W.; Jäckle, H. 2005: Drosophila BAP60 is an essential component of the Brahma complex, required for gene activation and repression. Journal of Molecular Biology 352(2): 329-337
Read, R.D.; Bach, E.A.; Cagan, R.L. 2004: Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways. Molecular and Cellular Biology 24(15): 6676-6689
Zordan, M.A.; Massironi, M.; Ducato, M.Giovanna.; Te Kronnie, G.; Costa, R.; Reggiani, C.; Chagneau, C.; Martin, J-René.; Megighian, A. 2005: Drosophila CAKI/CMG protein, a homolog of human CASK, is essential for regulation of neurotransmitter vesicle release. Journal of Neurophysiology 94(2): 1074-1083
Savvidou, E.; Cobbe, N.; Steffensen, S.ør.; Cotterill, S.; Heck, M.M.S. 2005: Drosophila CAP-D2 is required for condensin complex stability and resolution of sister chromatids. Journal of Cell Science 118(Part 11): 2529-2543
Karandikar, U.C.; Shaffer, J.; Bishop, C.P.; Bidwai, A.P. 2005: Drosophila CK2 phosphorylates Deadpan, a member of the HES family of basic-helix-loop-helix (bHLH) repressors. Molecular and Cellular Biochemistry 274(1-2): 133-139
Karandikar, U.C.; Trott, R.L.; Yin, J.; Bishop, C.P.; Bidwai, A.P. 2004: Drosophila CK2 regulates eye morphogenesis via phosphorylation of E(spl)M8. Mechanisms of Development 121(3): 273-286
Bose, A.; Kahali, B.; Zhang, S.; Lin, J.-M.; Allada, R.; Karandikar, U.; Bidwai, A.P. 2006: Drosophila CK2 regulates lateral-inhibition during eye and bristle development. Mechanisms of Development 123(9): 649-664
Collins, B.; Mazzoni, E.O.; Stanewsky, R.; Blau, J. 2006: Drosophila CRYPTOCHROME is a circadian transcriptional repressor. Current Biology: Cb 16(5): 441-449
Matera, A.G. 2006: Drosophila Cajal bodies: accessories not included. Journal of Cell Biology 172(6): 791-793
Swan, A.; Barcelo, G.; Schüpbach, T. 2005: Drosophila Cks30A interacts with Cdk1 to target Cyclin A for destruction in the female germline. Development 132(16): 3669-3678
Collier, L.S.; Suyama, K.; Anderson, J.H.; Scott, M.P. 2004: Drosophila Costal1 mutations are alleles of protein kinase a that modulate hedgehog signaling. Genetics 167(2): 783-796
Huertas, D.; Cortés, A.; Casanova, J.; Azorín, F. 2004: Drosophila DDP1, a multi-KH-domain protein, contributes to centromeric silencing and chromosome segregation. Current Biology: Cb 14(18): 1611-1620
Meulener, M.; Whitworth, A.J.; Armstrong-Gold, C.E.; Rizzu, P.; Heutink, P.; Wes, P.D.; Pallanck, L.J.; Bonini, N.M. 2005: Drosophila DJ-1 mutants are selectively sensitive to environmental toxins associated with Parkinson's disease. Current Biology: Cb 15(17): 1572-1577
Park, J.; Kim, S.Y.; Cha, G.-H.; Lee, S.B.; Kim, S.; Chung, J. 2005: Drosophila DJ-1 mutants show oxidative stress-sensitive locomotive dysfunction. Gene 361: 133-139
Takeuchi, R.; Ruike, T.; Nakamura, R-ichi.; Shimanouchi, K.; Kanai, Y.; Abe, Y.; Ihara, A.; Sakaguchi, K. 2006: Drosophila DNA polymerase zeta interacts with recombination repair protein 1, the Drosophila homologue of human abasic endonuclease 1. Journal of Biological Chemistry 281(17): 11577-11585
Bergman, C.M.; Carlson, J.W.; Celniker, S.E. 2004: Drosophila DNase I footprint database: a systematic genome annotation of transcription factor binding sites in the fruitfly, Drosophila melanogaster. Bioinformatics 21(8): 1747-1749
Yu, D.; Keene, A.C.; Srivatsan, A.; Waddell, S.; Davis, R.L. 2005: Drosophila DPM neurons form a delayed and branch-specific memory trace after olfactory classical conditioning. Cell 123(5): 945-957
Biswas, R.; Stein, D.; Stanley, E.R. 2006: Drosophila Dok is required for embryonic dorsal closure. Development 133(2): 217-227
Belenkaya, T.Y.; Han, C.; Yan, D.; Opoka, R.J.; Khodoun, M.; Liu, H.; Lin, X. 2004: Drosophila Dpp morphogen movement is independent of dynamin-mediated endocytosis but regulated by the glypican members of heparan sulfate proteoglycans. Cell 119(2): 231-244
Moon, N.-S.; Frolov, M.V.; Kwon, E.-J.; Di Stefano, L.; Dimova, D.K.; Morris, E.J.; Taylor-Harding, B.; White, K.; Dyson, N.J. 2005: Drosophila E2F1 has context-specific pro- and antiapoptotic properties during development. Developmental Cell 9(4): 463-475
Radford, S.J.; Goley, E.; Baxter, K.; McMahan, S.; Sekelsky, J. 2005: Drosophila ERCC1 is required for a subset of MEI-9-dependent meiotic crossovers. Genetics 170(4): 1737-1745
Wang, D.; Xu, M.; Liu, J.; Wan, Y.; Deng, H.; Dou, F.; Xie, W. 2006: Drosophila Ecp is a novel ribosome associated protein interacting with dRPL5. Biochimica et Biophysica Acta 1760(9): 1428-1433
Boyle, M.; Nighorn, A.; Thomas, J.B. 2006: Drosophila Eph receptor guides specific axon branches of mushroom body neurons. Development 133(9): 1845-1854
Dimitrijevic, N.; Dzitoyeva, S.; Satta, R.; Imbesi, M.; Yildiz, S.; Manev, H. 2005: Drosophila GABA(B) receptors are involved in behavioral effects of gamma-hydroxybutyric acid (GHB). European Journal of Pharmacology 519(3): 246-252
Hyun, S.; Lee, Y.; Hong, S-Tae.; Bang, S.; Paik, D.; Kang, J.; Shin, J.; Lee, J.; Jeon, K.; Hwang, S.; Bae, E.; Kim, J. 2005: Drosophila GPCR Han is a receptor for the circadian clock neuropeptide PDF. Neuron 48(2): 267-278
Cenci, C.; Gould, A.P. 2005: Drosophila Grainyhead specifies late programmes of neural proliferation by regulating the mitotic activity and Hox-dependent apoptosis of neuroblasts. Development 132(17): 3835-3845
Kuranaga, E.; Kanuka, H.; Tonoki, A.; Takemoto, K.; Tomioka, T.; Kobayashi, M.; Hayashi, S.; Miura, M. 2006: Drosophila IKK-related kinase regulates nonapoptotic function of caspases via degradation of IAPs. Cell 126(3): 583-596
Shapiro, R.S.; Anderson, K.V. 2006: Drosophila Ik2, a member of the I kappa B kinase family, is required for mRNA localization during oogenesis. Development 133(8): 1467-1475
Chang, C-Jui.; Goulding, S.; Adams, R.R.; Earnshaw, W.C.; Carmena, M. 2006: Drosophila Incenp is required for cytokinesis and asymmetric cell division during development of the nervous system. Journal of Cell Science 119(Pt 6): 1144-1153
Sarpal, R.; Todi, S.V.; Sivan-Loukianova, E.; Shirolikar, S.; Subramanian, N.; Raff, E.C.; Erickson, J.W.; Ray, K.; Eberl, D.F. 2003: Drosophila KAP interacts with the kinesin II motor subunit KLP64D to assemble chordotonal sensory cilia, but not sperm tails. Current Biology: Cb 13(19): 1687-1696
Savoian, M.S.; Gatt, M.K.; Riparbelli, M.G.; Callaini, G.; Glover, D.M. 2004: Drosophila Klp67A is required for proper chromosome congression and segregation during meiosis I. Journal of Cell Science 117(Pt 16): 3669-3677
Moussian, B.; Tång, E.; Tonning, A.; Helms, S.; Schwarz, H.; Nüsslein-Volhard, C.; Uv, A.E. 2006: Drosophila Knickkopf and Retroactive are needed for epithelial tube growth and cuticle differentiation through their specific requirement for chitin filament organization. Development 133(1): 163-171
Arquier, N.; Bourouis, M.; Colombani, J.; Léopold, P. 2005: Drosophila Lk6 kinase controls phosphorylation of eukaryotic translation initiation factor 4E and promotes normal growth and development. Current Biology: Cb 15(1): 19-23
He, Y.; Emoto, K.; Fang, X.; Ren, N.; Tian, X.; Jan, Y-Nung.; Adler, P.N. 2005: Drosophila Mob family proteins interact with the related tricornered (Trc) and warts (Wts) kinases. Molecular Biology of the Cell 16(9): 4139-4152
Jin, Z.; Homola, E.M.; Goldbach, P.; Choi, Y.; Brill, J.A.; Campbell, S.D. 2005: Drosophila Myt1 is a Cdk1 inhibitory kinase that regulates multiple aspects of cell cycle behavior during gametogenesis. Development 132(18): 4075-4085
Ting, C-Yuan.; Yonekura, S.; Chung, P.; Hsu, S-Ning.; Robertson, H.M.; Chiba, A.; Lee, C-Hon. 2005: Drosophila N-cadherin functions in the first stage of the two-stage layer-selection process of R7 photoreceptor afferents. Development 132(5): 953-963
Sakata, T.; Sakaguchi, H.; Tsuda, L.; Higashitani, A.; Aigaki, T.; Matsuno, K.; Hayashi, S. 2004: Drosophila Nedd4 regulates endocytosis of notch and suppresses its ligand-independent activation. Current Biology: Cb 14(24): 2228-2236
Prigent, C.; Glover, D.M.; Giet, R.ég. 2005: Drosophila Nek2 protein kinase knockdown leads to centrosome maturation defects while overexpression causes centrosome fragmentation and cytokinesis failure. Experimental Cell Research 303(1): 1-13
Gu, G.; Yang, J.; Mitchell, K.A.; O'Tousa, J.E. 2004: Drosophila ninaB and ninaD act outside of retina to produce rhodopsin chromophore. Journal of Biological Chemistry 279(18): 18608-18613
Xu, P.; Atkinson, R.; Jones, D.N.M.; Smith, D.P. 2005: Drosophila OBP LUSH is required for activity of pheromone-sensitive neurons. Neuron 45(2): 193-200
Kim, S.-E.; Cho, J.-Y.; Kim, K.-S.; Lee, S.-J.; Lee, K.-H.; Choi, K.-Y. 2004: Drosophila PI3 kinase and Akt involved in insulin-stimulated proliferation and ERK pathway activation in Schneider cells. Cellular Signalling 16(11): 1309-1317
Adelman, K.; Wei, W.; Ardehali, M.B.; Werner, J.; Zhu, B.; Reinberg, D.; Lis, J.T. 2006: Drosophila Paf1 modulates chromatin structure at actively transcribed genes. Molecular and Cellular Biology 26(1): 250-260
Teixeira, Lís.; Rabouille, C.; Rørth, P.; Ephrussi, A.; Vanzo, N.F. 2003: Drosophila Perilipin/ADRP homologue Lsd2 regulates lipid metabolism. Mechanisms of Development 120(9): 1071-1081
Zhu, X.; Sen, J.; Stevens, L.; Goltz, J.S.; Stein, D. 2005: Drosophila pipe protein activity in the ovary and the embryonic salivary gland does not require heparan sulfate glycosaminoglycans. Development 132(17): 3813-3822
Gao, Z.; Joseph, E.; Ruden, D.M.; Lu, X. 2004: Drosophila Pkd2 is haploid-insufficient for mediating optimal smooth muscle contractility. Journal of Biological Chemistry 279(14): 14225-14231
Ayoob, J.C.; Terman, J.R.; Kolodkin, A.L. 2006: Drosophila Plexin B is a Sema-2a receptor required for axon guidance. Development 133(11): 2125-2135
Abrescia, C.; Sjöstrand, D.; Kjaer, S.; Ibáñez, C.F. 2005: Drosophila RET contains an active tyrosine kinase and elicits neurotrophic activities in mammalian cells. Febs Letters 579(17): 3789-3796
Dubrovsky, E.B.; Dubrovskaya, V.A.; Levinger, L.; Schiffer, S.; Marchfelder, A. 2004: Drosophila RNase Z processes mitochondrial and nuclear pre-tRNA 3' ends in vivo. Nucleic Acids Research 32(1): 255-262
Verdier, V.; Johndrow, J.E.; Betson, M.; Chen, G.-C.; Hughes, D.A.; Parkhurst, S.M.; Settleman, J. 2006: Drosophila Rho-kinase (DRok) is required for tissue morphogenesis in diverse compartments of the egg chamber during oogenesis. Developmental Biology 297(2): 417-432
Sanny, J.; Chui, V.; Langmann, C.; Pereira, C.; Zahedi, B.; Harden, N. 2006: Drosophila RhoGAP68F is a putative GTPase activating protein for RhoA participating in gastrulation. Development Genes and Evolution 216(9): 543-550
Rogers, S.L.; Wiedemann, U.; Häcker, U.; Turck, C.; Vale, R.D. 2004: Drosophila RhoGEF2 associates with microtubule plus ends in an EB1-dependent manner. Current Biology: Cb 14(20): 1827-1833
David, N., B.; Martin, C., A.; Segalen, M.; Rosenfeld, F.; Schweisguth, F.; Bellaiche, Y. 2005: Drosophila Ric-8 regulates G alpha i cortical localization to promote G alpha i-dependent planar orientation of the mitotic spindle during asymmetric cell division. Nature Cell Biology 7(11): 1083-1090
Tenney, K.; Gerber, M.; Ilvarsonn, A.; Schneider, J.; Gause, M.; Dorsett, D.; Eissenberg, J.C.; Shilatifard, A. 2006: Drosophila Rtf1 functions in histone methylation, gene expression, and Notch signaling. Proceedings of the National Academy of Sciences of the United States of America 103(32): 11970-11974
Kalinina, E.; Fontenele-Neto, J.D.; Fricker, L.D. 2006: Drosophila S2 cells produce multiple forms of carboxypeptidase D with different intracellular distributions. Journal of Cellular Biochemistry 99(3): 770-783
Cheng, L.W.; Portnoy, D.A. 2003: Drosophila S2 cells: an alternative infection model for Listeria monocytogenes. Cellular Microbiology 5(12): 875-885
Buescher, M.; Svendsen, P.C.; Tio, M.; Miskolczi-McCallum, C.; Tear, G.; Brook, W.J.; Chia, W. 2004: Drosophila T box proteins break the symmetry of hedgehog-dependent activation of wingless. Current Biology: Cb 14(19): 1694-1702
Zhuang, Z.-H.; Sun, L.; Kong, L.; Hu, J.-H.; Yu, M.-C.; Reinach, P.; Zang, J.-W.; Ge, B.-X. 2006: Drosophila TAB2 is required for the immune activation of JNK and NF-kappaB. Cellular Signalling 18(7): 964-970
Hyman, C.A.; Bartholin, L.; Newfeld, S.J.; Wotton, D. 2003: Drosophila TGIF proteins are transcriptional activators. Molecular and Cellular Biology 23(24): 9262-9274
Montell, C. 2005: Drosophila TRP channels. Pflugers Archiv: European Journal of Physiology 451(1): 19-28
Wakiyama, M.; Matsumoto, T.; Yokoyama, S. 2005: Drosophila U6 promoter-driven short hairpin RNAs effectively induce RNA interference in Schneider 2 cells. Biochemical and Biophysical Research Communications 331(4): 1163-1170
Abaza, I.; Coll, O.; Patalano, S.; Gebauer, Fátima. 2006: Drosophila UNR is required for translational repression of male-specific lethal 2 mRNA during regulation of X-chromosome dosage compensation. Genes and Development 20(3): 380-389
Smith, M.; Bhaskar, V.; Fernandez, J.; Courey, A.J. 2004: Drosophila Ulp1, a nuclear pore-associated SUMO protease, prevents accumulation of cytoplasmic SUMO conjugates. Journal of Biological Chemistry 279(42): 43805-43814
Pulipparacharuvil, S.; Akbar, M.A.; Ray, S.; Sevrioukov, E.A.; Haberman, A.S.; Rohrer, J.; Krämer, H. 2005: Drosophila Vps16A is required for trafficking to lysosomes and biogenesis of pigment granules. Journal of Cell Science 118(Part 16): 3663-3673
Stumpff, J.; Duncan, T.; Homola, E.; Campbell, S.D.; Su, T.T. 2004: Drosophila Wee1 kinase regulates Cdk1 and mitotic entry during embryogenesis. Current Biology: Cb 14(23): 2143-2148
Zhai, L.; Chaturvedi, D.; Cumberledge, S. 2004: Drosophila wnt-1 undergoes a hydrophobic modification and is targeted to lipid rafts, a process that requires porcupine. Journal of Biological Chemistry 279(32): 33220-33227
Ganguly, A.; Jiang, J.; Ip, Y.T. 2005: Drosophila WntD is a target and an inhibitor of the Dorsal/Twist/Snail network in the gastrulating embryo. Development 132(15): 3419-3429
Sano, Y.; Akimaru, H.; Okamura, T.; Nagao, T.; Okada, M.; Ishii, S. 2005: Drosophila activating transcription factor-2 is involved in stress response via activation by p38, but not c-Jun NH(2)-terminal kinase. Molecular Biology of the Cell 16(6): 2934-2946
Benach, J.; Winberg, J.-O.; Svendsen, J.-S.; Atrian, S.íl.; Gonzàlez-Duarte, R.; Ladenstein, R. 2005: Drosophila alcohol dehydrogenase: acetate-enzyme interactions and novel insights into the effects of electrostatics on catalysis. Journal of Molecular Biology 345(3): 579-598
Mathew, D.; Popescu, A.; Budnik, V. 2003: Drosophila amphiphysin functions during synaptic Fasciclin II membrane cycling. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 23(33): 10710-10716
Vilela, C., R.; Valente, V., L.S.; Basso-Da-Silva, L. 2004: Drosophila angustibucca Duda sensu Frota-Pessoa is an undescribed species (Diptera, Drosophilidae). Revista Brasileira de Entomologia 48(2): 233-238
Doerflinger, Hélène.; Benton, R.; Torres, I.L.; Zwart, M.F.; St Johnston, D. 2006: Drosophila anterior-posterior polarity requires actin-dependent PAR-1 recruitment to the oocyte posterior. Current Biology: Cb 16(11): 1090-1095
Deshpande, G.; Calhoun, G.; Schedl, P. 2005: Drosophila argonaute-2 is required early in embryogenesis for the assembly of centric/centromeric heterochromatin, nuclear division, nuclear migration, and germ-cell formation. Genes and Development 19(14): 1680-1685
Wolf, M.J.; Amrein, H.; Izatt, J.A.; Choma, M.A.; Reedy, M.C.; Rockman, H.A. 2006: Drosophila as a model for the identification of genes causing adult human heart disease. Proceedings of the National Academy of Sciences of the United States of America 103(5): 1394-1399
Koh, Young-Ho 2006: Drosophila as a model organism for investigating molecular and cellular etiologies underlying complex neurological disorders in humans. JOURNAL OF ASIA PACIFIC ENTOMOLOGY 9(2): 75-84
Oikemus, S.R.; McGinnis, N.; Queiroz-Machado, J.; Tukachinsky, H.; Takada, S.; Sunkel, C.E.; Brodsky, M.H. 2004: Drosophila atm/telomere fusion is required for telomeric localization of HP1 and telomere position effect. Genes and Development 18(15): 1850-1861
Mackay, T.F.; Lyman, R.F. 2005: Drosophila bristles and the nature of quantitative genetic variation. Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 360(1459): 1513-1527
Perrin, L.; Monier, B.; Ponzielli, R.; Astier, M.; Semeriva, M. 2004: Drosophila cardiac tube organogenesis requires multiple phases of Hox activity. Developmental Biology 272(2): 419-431
Daish, T.J.; Mills, K.; Kumar, S. 2004: Drosophila caspase DRONC is required for specific developmental cell death pathways and stress-induced apoptosis. Developmental Cell 7(6): 909-915
Kanuka, H.; Kuranaga, E.; Takemoto, K.; Hiratou, T.; Okano, H.; Miura, M. 2005: Drosophila caspase transduces Shaggy/GSK-3 beta kinase activity in neural precursor development. EMBO (European Molecular Biology Organization) Journal 24(21): 3793-3806
Nicolas, E.; Preat, T. 2005: Drosophila central brain formation requires Robo proteins. Development Genes and Evolution 215(10): 530-536
Naim, V.; Imarisio, S.; Di Cunto, F.; Gatti, M.; Bonaccorsi, S. 2004: Drosophila citron kinase is required for the final steps of cytokinesis. Molecular Biology of the Cell 15(11): 5053-5063
Valdeolmillos, A.; Rufas, J.S.; Suja, Jé.A.; Vass, S.; Heck, M.M.S.; Martínez-A, C.; Barbero, Jé.L. 2004: Drosophila cohesins DSA1 and Drad21 persist and colocalize along the centromeric heterochromatin during mitosis. Biology of the Cell 96(6): 457-462
Faivre-Sarrailh, C.; Banerjee, S.; Li, J.; Hortsch, M.; Laval, M.; Bhat, M.A. 2004: Drosophila contactin, a homolog of vertebrate contactin, is required for septate junction organization and paracellular barrier function. Development 131(20): 4931-4942
Glasscock, E.; Tanouye, M.A. 2005: Drosophila couch potato mutants exhibit complex neurological abnormalities including epilepsy phenotypes. Genetics 169(4): 2137-2149
Kiehart, D.P.; Franke, J.D.; Chee, M.K.; Montague, R.A.; Chen, T-Ling.; Roote, J.; Ashburner, M. 2004: Drosophila crinkled, mutations of which disrupt morphogenesis and cause lethality, encodes fly myosin VIIA. Genetics 168(3): 1337-1352
Nakamura, A.; Sato, K.; Hanyu-Nakamura, K. 2004: Drosophila cup is an eIF4E binding protein that associates with Bruno and regulates oskar mRNA translation in oogenesis. Developmental Cell 6(1): 69-78
Frei, C.; Edgar, B.A. 2004: Drosophila cyclin D/Cdk4 requires Hif-1 prolyl hydroxylase to drive cell growth. Developmental Cell 6(2): 241-251
Costa, E.; Canudas, S.; Garcia-Bassets, I.; Pérez, S.; Fernández, I.; Giralt, E.; Azorín, F.; Espinás, M.L.ïs. 2006: Drosophila dSAP18 is a nuclear protein that associates with chromosomes and the nuclear matrix, and interacts with pinin, a protein factor involved in RNA splicing. Chromosome Research: An International Journal on the Molecular Supramolecular and Evolutionary Aspects of Chromosome Biology 14(5): 515-526
Takata, K.-i.; Yoshida, H.; Yamaguchi, M.; Sakaguchi, K. 2004: Drosophila damaged DNA-binding protein 1 is an essential factor for development. Genetics 168(2): 855-865
Lin, M-Der.; Fan, S-Jung.; Hsu, W-Shan.; Chou, T-Bin. 2006: Drosophila decapping protein 1, dDcp1, is a component of the oskar mRNP complex and directs its posterior localization in the oocyte. Developmental Cell 10(5): 601-613
Hori, K.; Fostier, M.; Ito, M.; Fuwa, T.J.; Go, M.J.; Okano, H.; Baron, M.; Matsuno, K. 2004: Drosophila deltex mediates suppressor of Hairless-independent and late-endosomal activation of Notch signaling. Development 131(22): 5527-5537
Min, K.-J.; Tatar, M. 2006: Drosophila diet restriction in practice: do flies consume fewer nutrients?. Mechanisms of Ageing and Development 127(1): 93-96
Affleck, J.G.; Al-Batayneh, K.M.; Neumann, K.; Cole, S.P.C.; Walker, V.K. 2006: Drosophila dihydrofolate reductase mutations confer antifolate resistance to mammalian cells. European Journal of Pharmacology 529(1-3): 71-78
Hayashi, Y.; Kato, M.; Seto, H.; Yamaguchi, M. 2006: Drosophila distal-less negatively regulates dDREF by inhibiting its DNA binding activity. Biochimica et Biophysica Acta 1759(7): 359-366
Keene, A.C.; Krashes, M.J.; Leung, B.; Bernard, J.A.; Waddell, S. 2006: Drosophila dorsal paired medial neurons provide a general mechanism for memory consolidation. Current Biology: Cb 16(15): 1524-1530
Thomer, M.; May, N.R.; Aggarwal, B.D.; Kwok, G.; Calvi, B.R. 2004: Drosophila double-parked is sufficient to induce re-replication during development and is regulated by cyclin E/CDK2. Development 131(19): 4807-4818
Preuss, F.; Fan, J.-Y.; Kalive, M.; Bao, S.; Schuenemann, E.; Bjes, E.S.; Price, J.L. 2004: Drosophila doubletime mutations which either shorten or lengthen the period of circadian rhythms decrease the protein kinase activity of casein kinase i. Molecular and Cellular Biology 24(2): 886-898
Hortsch, M. 2003: Drosophila Echinoid is an antagonist of Egfr signalling, but is not a member of the L1-type family of cell adhesion molecules. Development 130(22): 5295
Anonymous 2006: Drosophila elegans Bock & Wheeler, 1972 (Insecta, Diptera): specific name conserved. Bulletin of Zoological Nomenclature 63(1): 74-75
Wang, W.; Struhl, G. 2004: Drosophila Epsin mediates a select endocytic pathway that DSL ligands must enter to activate Notch. Development 131(21): 5367-5380
Langevin, J.; Morgan, M.J.; Sibarita, J-Baptiste.; Aresta, S.; Murthy, M.; Schwarz, T.; Camonis, J.; Bellaïche, Y. 2005: Drosophila exocyst components Sec5, Sec6, and Sec15 regulate DE-Cadherin trafficking from recycling endosomes to the plasma membrane. Developmental Cell 9(3): 365-376
Lim, J.; Choi, K.-W. 2004: Drosophila eye disc margin is a center for organizing long-range planar polarity. Genesis 39(1): 26-37
Mathews, W.R.; Wang, F.; Eide, D.J.; Van Doren, M. 2005: Drosophila fear of intimacy encodes a Zrt/IRT-like protein (ZIP) family zinc transporter functionally related to mammalian ZIP proteins. Journal of Biological Chemistry 280(1): 787-795
Swan, A.; Schüpbach, T. 2005: Drosophila female meiosis and embryonic syncytial mitosis use specialized Cks and CDC20 proteins for cyclin destruction. Cell Cycle 4(10): 1332-1334
Peng, Y.; Stoleru, D.; Levine, J.D.; Hall, J.C.; Rosbash, M. 2003: Drosophila free-running rhythms require intercellular communication. Plos Biology 1(1): E13
Cairrão, F.át.; Arraiano, C.íl.; Newbury, S. 2005: Drosophila gene tazman, an orthologue of the yeast exosome component Rrp44p/Dis3, is differentially expressed during development. Developmental Dynamics: An Official Publication of the American Association of Anatomists 232(3): 733-737
Resino, J.; García-Bellido, A. 2004: Drosophila genetic variants that change cell size and rate of proliferation affect cell communication and hence patterning. Mechanisms of Development 121(4): 351-364
Lee, L.A.; Lee, E.; Anderson, M.A.; Vardy, L.; Tahinci, E.; Ali, S.M.; Kashevsky, H.; Benasutti, M.; Kirschner, M.W.; Orr-Weaver, T.L. 2005: Drosophila genome-scale screen for PAN GU kinase substrates identifies Mat89Bb as a cell cycle regulator. Developmental Cell 8(3): 435-442
Kohyama-Koganeya, A.; Sasamura, T.; Oshima, E.; Suzuki, E.; Nishihara, S.; Ueda, R.; Hirabayashi, Y. 2004: Drosophila glucosylceramide synthase: a negative regulator of cell death mediated by proapoptotic factors. Journal of Biological Chemistry 279(34): 35995-36002
Dutta, D.; Shaw, S.; Maqbool, T.; Pandya, H.; Vijayraghavan, K. 2005: Drosophila Heartless acts with Heartbroken/Dof in muscle founder differentiation. PLOS Biology 3(10): E337
Marek, L.R.; Bale, A.E. 2006: Drosophila homologs of FANCD2 and FANCL function in DNA repair. Dna Repair 5(11): 1317-1326
Majumdar, A.; Ramagiri, S.; Rikhy, R. 2006: Drosophila homologue of Eps15 is essential for synaptic vesicle recycling. Experimental Cell Research 312(12): 2288-2298
Vodovar, N.; Vinals, M.; Liehl, P.; Basset, A.; Degrouard, J.; Spellman, P.; Boccard, F.éd.ér.; Lemaitre, B. 2005: Drosophila host defense after oral infection by an entomopathogenic Pseudomonas species. Proceedings of the National Academy of Sciences of the United States of America 102(32): 11414-11419
Kambris, Z.; Brun, S.; Jang, I.-H.; Nam, H.-J.; Romeo, Y.; Takahashi, K.; Lee, W.-J.; Ueda, R.; Lemaitre, B. 2006: Drosophila immunity: a large-scale in vivo RNAi screen identifies five serine proteases required for Toll activation. Current Biology: Cb 16(8): 808-813
Marsh, J.L.; Thompson, L.M. 2006: Drosophila in the study of neurodegenerative disease. Neuron 52(1): 169-178
Fischer, J.A.; Acosta, S.; Kenny, A.; Cater, C.; Robinson, C.; Hook, J. 2004: Drosophila klarsicht has distinct subcellular localization domains for nuclear envelope and microtubule localization in the eye. Genetics 168(3): 1385-1393
Teleman, A.A.; Maitra, S.; Cohen, S.M. 2006: Drosophila lacking microRNA miR-278 are defective in energy homeostasis. Genes and Development 20(4): 417-422
Brummel, T.; Ching, A.; Seroude, L.; Simon, A.F.; Benzer, S. 2004: Drosophila lifespan enhancement by exogenous bacteria. Proceedings of the National Academy of Sciences of the United States of America 101(35): 12974-12979
Fauny, J.D.; Silber, J.ël.; Zider, A. 2005: Drosophila Lipid Storage Droplet 2 gene (Lsd-2) is expressed and controls lipid storage in wing imaginal discs. Developmental Dynamics: An Official Publication of the American Association of Anatomists 232(3): 725-732
Phillips, K. 2004: Drosophila lose their boost. Journal of Experimental Biology 207(20): III
Rattner, B.P.; Meller, V.H. 2004: Drosophila male-specific lethal 2 protein controls sex-specific expression of the roX genes. Genetics 166(4): 1825-1832
D'Alterio, C.; Tran, D.D.D.; Yeung, M.W.Y.A.; Hwang, M.S.H.; Li, M.A.; Arana, C.J.; Mulligan, V.K.; Kubesh, M.; Sharma, P.; Chase, M.; Tepass, U.; Godt, D. 2005: Drosophila melanogaster Cad99C, the orthologue of human Usher cadherin PCDH15, regulates the length of microvilli. Journal of Cell Biology 171(3): 549-558
Gisselmann, G.; Plonka, J.; Pusch, H.; Hatt, H. 2004: Drosophila melanogaster GRD and LCCH3 subunits form heteromultimeric GABA-gated and cation channels. British Journal of Pharmacology 142(3): 409-413
Brodsky, M.H.; Weinert, B.T.; Tsang, G.; Rong, Y.S.; McGinnis, N.M.; Golic, K.G.; Rio, D.C.; Rubin, G.M. 2004: Drosophila melanogaster MNK/Chk2 and p53 regulate multiple DNA repair and apoptotic pathways following DNA damage. Molecular and Cellular Biology 24(3): 1219-1231
Thomas, J.E.; Rylett, C.M.; Carhan, A.; Bland, N.D.; Bingham, R.J.; Shirras, A.D.; Turner, A.J.; Isaac, R.Elwyn. 2005: Drosophila melanogaster NEP2 is a new soluble member of the neprilysin family of endopeptidases with implications for reproduction and renal function. Biochemical Journal 386(Pt 2): 357-366
Castro, J.P.; Carareto, C.M.A. 2004: Drosophila melanogaster P transposable elements: mechanisms of transposition and regulation. Genetica 121(2): 107-118
Vaché, C.; Camares, O.; De Graeve, F.; Dastugue, B.; Meiniel, A.; Vaury, C.; Pellier, S.; Leoz-Garziandia, E.; Bamdad, M. 2006: Drosophila melanogaster p-glycoprotein: a membrane detoxification system toward polycyclic aromatic hydrocarbon pollutants. Environmental Toxicology and Chemistry 25(2): 572-580
Malmanche, N.; Clark, D.V. 2004: Drosophila melanogaster Prat, a purine de novo synthesis gene, has a pleiotropic maternal-effect phenotype. Genetics 168(4): 2011-2023
Williams, M.J.; Ando, I.; Hultmark, D. 2005: Drosophila melanogaster Rac2 is necessary for a proper cellular immune response. Genes to Cells: Devoted to Molecular and Cellular Mechanisms 10(8): 813-823
Elwell, C.; Engel, J.N. 2005: Drosophila melanogaster S2 cells: a model system to study Chlamydia interaction with host cells. Cellular Microbiology 7(5): 725-739
Acharya, U.; Edwards, M.B.; Jorquera, R.A.; Silva, H.; Nagashima, K.; Labarca, P.; Acharya, J.K. 2006: Drosophila melanogaster Scramblases modulate synaptic transmission. Journal of Cell Biology 173(1): 69-82
Spresser, C.R.; Carlson, K.A. 2005: Drosophila melanogaster as a complementary system for studying HIV-1-related genes and proteins. Journal of Neuroscience Research 80(4): 451-455
Needham, A.J.; Kibart, M.; Crossley, H.; Ingham, P.W.; Foster, S.J. 2004: Drosophila melanogaster as a model host for Staphylococcus aureus infection. Microbiology 150(Part 7): 2347-2355
Hagedorn, E.J.; Bayraktar, J.L.; Kandachar, V.R.; Bai, T.; Englert, D.M.; Chang, H.C. 2006: Drosophila melanogaster auxilin regulates the internalization of Delta to control activity of the Notch signaling pathway. Journal of Cell Biology 173(3): 443-452
Vérollet, C.; Colombié, N.; Daubon, T.; Bourbon, H-Marc.; Wright, M.; Raynaud-Messina, B. 2006: Drosophila melanogaster gamma-TuRC is dispensable for targeting gamma-tubulin to the centrosome and microtubule nucleation. Journal of Cell Biology 172(4): 517-528
Guedes, S.d.M.; Vitorino, R.; Tomer, K.; Domingues, M.R.ár.M.; Correia, A.J.F.; Amado, F.; Domingues, P. 2003: Drosophila melanogaster larval hemolymph protein mapping. Biochemical and Biophysical Research Communications 312(3): 545-554
Dillon, M.E.; Frazier, M.R. 2006: Drosophila melanogaster locomotion in cold thin air. Journal of Experimental Biology 209(Part 2): 364-371
Ashburner, M.; Bergman, C.M. 2005: Drosophila melanogaster: a case study of a model genomic sequence and its consequences. Genome Research 15(12): 1661-1667
Song, Y-Han. 2005: Drosophila melanogaster: a model for the study of DNA damage checkpoint response. Molecules and Cells 19(2): 167-179
Roberts, D.B. 2006: Drosophila melanogaster: the model organism. Entomologia Experimentalis et Applicata 121(2): 93-103
Teleman, A.A.; Chen, Y.-W.; Cohen, S.M. 2005: Drosophila Melted modulates FOXO and TOR activity. Developmental Cell 9(2): 271-281
Aboobaker, A.A.; Tomancak, P.; Patel, N.; Rubin, G.M.; Lai, E.C. 2005: Drosophila micro RNAs exhibit diverse spatial expression patterns during embryonic development. Proceedings of the National Academy of Sciences of the United States of America 102(50): 18017-18022
Matsushima, Y.; Garesse, R.; Kaguni, L.S. 2004: Drosophila mitochondrial transcription factor B2 regulates mitochondrial DNA copy number and transcription in schneider cells. Journal of Biological Chemistry 279(26): 26900-26905
Manev, H.; Dimitrijevic, N. 2004: Drosophila model for in vivo pharmacological analgesia research. European Journal of Pharmacology 491(2-3): 207-208
Whitworth, A.J.; Wes, P.D.; Pallanck, L.J. 2006: Drosophila models pioneer a new approach to drug discovery for Parkinson's disease. Drug Discovery Today 11(3-4): 119-126
Mendive, F.M.; Van Loy, T.; Claeysen, S.; Poels, J.; Williamson, M.; Hauser, F.; Grimmelikhuijzen, C.J.P.; Vassart, G.; Vanden Broeck, J. 2005: Drosophila molting neurohormone bursicon is a heterodimer and the natural agonist of the orphan receptor DLGR2. Febs Letters 579(10): 2171-2176
Cammarato, A.; Hatch, V.; Saide, J.; Craig, R.; Sparrow, J.C.; Tobacman, L.S.; Lehman, W. 2004: Drosophila muscle regulation characterized by electron microscopy and three-dimensional reconstruction of thin filament mutants. Biophysical Journal 86(3): 1618-1624
Watanabe, S.; Ikebe, R.; Ikebe, M. 2006: Drosophila myosin VIIA is a high duty ratio motor with a unique kinetic mechanism. Journal of Biological Chemistry 281(11): 7151-7160
Wang, H.; Chia, W. 2005: Drosophila neural progenitor polarity and asymmetric division. Biology of the Cell 97(1): 63-74
Karcavich, R.; Doe, C.Q. 2005: Drosophila neuroblast 7-3 cell lineage: a model system for studying programmed cell death, Notch/Numb signaling, and sequential specification of ganglion mother cell identity. Journal of Comparative Neurology 481(3): 240-251
Yu, F.; Kuo, C.T.; Jan, Y.Nung. 2006: Drosophila neuroblast asymmetric cell division: recent advances and implications for stem cell biology. Neuron 51(1): 13-20
Wen, T.; Parrish, C.A.; Xu, D.; Wu, Q.; Shen, P. 2005: Drosophila neuropeptide F and its receptor, NPFR1, define a signaling pathway that acutely modulates alcohol sensitivity. Proceedings of the National Academy of Sciences of the United States of America 102(6): 2141-2146
Cui, W.; Sproul, L.R.; Gustafson, S.M.; Matthies, H.J.G.; Gilbert, S.P.; Hawley, R.S. 2005: Drosophila Nod protein binds preferentially to the plus ends of microtubules and promotes microtubule polymerization in vitro. Molecular Biology of the Cell 16(11): 5400-5409
Wahlström, G.; Lahti, V-Pekka.; Pispa, J.; Roos, C.; Heino, T.I. 2004: Drosophila non-muscle alpha-actinin is localized in nurse cell actin bundles and ring canals, but is not required for fertility. Mechanisms of Development 121(11): 1377-1391
Barros, C.S.; Phelps, C.B.; Brand, A.H. 2003: Drosophila nonmuscle myosin II promotes the asymmetric segregation of cell fate determinants by cortical exclusion rather than active transport. Developmental Cell 5(6): 829-840
De Rosny, E.; de Groot, A.; Jullian-Binard, C.; Gaillard, J.; Borel, F.; Pebay-Peyroula, E.; Fontecilla-Camps, J.C.; Jouve, H.él.èn.M. 2006: Drosophila nuclear receptor E75 is a thiolate hemoprotein. Biochemistry 45(32): 9727-9734
Bartoszewski, S.ła.; Luschnig, S.; Desjeux, I.; Grosshans, J.ör.; Nüsslein-Volhard, C. 2004: Drosophila p24 homologues eclair and baiser are necessary for the activity of the maternally expressed Tkv receptor during early embryogenesis. Mechanisms of Development 121(10): 1259-1273
Kim, T.-Hee; Park, S.-Young; Chung, H.-Young; Kim, B.-Gee; Yoo, M.-Ae; Kim, Y.-Shin 2005: Drosophila p53 upregulates VDAC gene expression that is linked to apoptosis. Korean Journal of Genetics 27(1): 89-96
Pesah, Y.; Pham, T.; Burgess, H.; Middlebrooks, B.; Verstreken, P.; Zhou, Y.; Harding, M.; Bellen, H.; Mardon, G. 2004: Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131(9): 2183-2194
Choe, K.-M.; Lee, H.; Anderson, K.V. 2005: Drosophila peptidoglycan recognition protein LC (PGRP-LC) acts as a signal-transducing innate immune receptor. Proceedings of the National Academy of Sciences of the United States of America 102(4): 1122-1126
Tulin, A.; Naumova, N.M.; Menon, A.K.; Spradling, A.C. 2006: Drosophila poly(ADP-ribose) glycohydrolase mediates chromatin structure and SIR2-dependent silencing. Genetics 172(1): 363-371
Maier, D.; Hausser, A.; Nagel, A.C.; Link, G.; Kugler, S.J.; Wech, I.; Pfizenmaier, K.; Preiss, A. 2006: Drosophila protein kinase D is broadly expressed and a fraction localizes to the Golgi compartment. Gene Expression Patterns: Gep 6(8): 849-856
Qi, D.; Jin, H.; Lilja, T.; Mannervik, M. 2006: Drosophila Reptin and other TIP60 complex components promote generation of silent chromatin. Genetics 174(1): 241-251
Ditch, L.M.; Shirangi, T.; Pitman, J.L.; Latham, K.L.; Finley, K.D.; Edeen, P.T.; Taylor, B.J.; McKeown, M. 2005: Drosophila retained/dead ringer is necessary for neuronal pathfinding, female receptivity and repression of fruitless independent male courtship behaviors. Development 132(1): 155-164
Ni, J.-Q.; Liu, L.-P.; Hess, D.; Rietdorf, J.; Sun, F.-L. 2006: Drosophila ribosomal proteins are associated with linker histone H1 and suppress gene transcription. Genes and Development 20(14): 1959-1973
Kreisköther, N.; Reichert, N.; Buttgereit, D.; Hertenstein, A.; Fischbach, K-Friedrich.; Renkawitz-Pohl, R. 2006: Drosophila rolling pebbles colocalises and putatively interacts with alpha-Actinin and the Sls isoform Zormin in the Z-discs of the sarcomere and with Dumbfounded/Kirre, alpha-Actinin and Zormin in the terminal Z-discs. Journal of Muscle Research and Cell Motility 27(1): 93-106
Osterwalder, T.; Kuhnen, A.; Leiserson, W.M.; Kim, Y.-S.; Keshishian, H. 2004: Drosophila serpin 4 functions as a neuroserpin-like inhibitor of subtilisin-like proprotein convertases. Journal of Neuroscience: the Official Journal of the Society for Neuroscience 24(24): 5482-5491
Peng, J.; Zipperlen, P.; Kubli, E. 2005: Drosophila sex-peptide stimulates female innate immune system after mating via the Toll and Imd pathways. Current Biology: Cb 15(18): 1690-1694
Lee, K.-S.; You, K.-H.; Choo, J.-K.; Han, Y.-M.; Yu, K. 2004: Drosophila short neuropeptide F regulates food intake and body size. Journal of Biological Chemistry 279(49): 50781-50789
Casso, D.J.; Tanda, S.; Biehs, B.; Martoglio, B.; Kornberg, T.B. 2005: Drosophila signal peptide peptidase is an essential protease for larval development. Genetics 170(1): 139-148
Ballard, J.W.O. 2005: Drosophila simulans as a novel model for studying mitochondrial metabolism and aging. Experimental Gerontology 40(10): 763-773
Riedl, C.A.L.; Neal, S.J.; Robichon, A.; Westwood, J.Timothy.; Sokolowski, M.B. 2005: Drosophila soluble guanylyl cyclase mutants exhibit increased foraging locomotion: behavioral and genomic investigations. Behavior Genetics 35(3): 231-244
Sherwood, N.Tang.; Sun, Q.; Xue, M.; Zhang, B.; Zinn, K. 2004: Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function. Plos Biology 2(12): e429
Coulson, M.; Robert, S.; Saint, R. 2005: Drosophila starvin encodes a tissue-specific BAG-domain protein required for larval food uptake. Genetics 171(4): 1799-1812
Lanzotti, D.J.; Kupsco, J.M.; Yang, X.-C.; Dominski, Z.; Marzluff, W.F.; Duronio, R.J. 2004: Drosophila stem-loop binding protein intracellular localization is mediated by phosphorylation and is required for cell cycle-regulated histone mRNA expression. Molecular Biology of the Cell 15(3): 1112-1123
Loewen, C.A.; Royer, S.M.; Reist, N.E. 2006: Drosophila synaptotagmin I null mutants show severe alterations in vesicle populations but calcium-binding motif mutants do not. Journal of Comparative Neurology 496(1): 1-12
True, J.R.; Yeh, S-Dan.; Hovemann, B.T.; Kemme, T.; Meinertzhagen, I.A.; Edwards, T.N.; Liou, S-Ren.; Han, Q.; Li, J. 2005: Drosophila tan encodes a novel hydrolase required in pigmentation and vision. Plos Genetics 1(5): E63
Zhang, Y.; Billington, C.J.; Pan, D.; Neufeld, T.P. 2006: Drosophila target of rapamycin kinase functions as a multimer. Genetics 172(1): 355-362
Secombe, J.; Parkhurst, S.M. 2004: Drosophila Topors is a RING finger-containing protein that functions as a ubiquitin-protein isopeptide ligase for the hairy basic helix-loop-helix repressor protein. Journal of Biological Chemistry 279(17): 17126-17133
Thomson, T.; Lasko, P. 2004: Drosophila tudor is essential for polar granule assembly and pole cell specification, but not for posterior patterning. Genesis 40(3): 164-170
Fritsch, C.; Ploeger, G.; Arndt-Jovin, D.J. 2006: Drosophila under the lens: imaging from chromosomes to whole embryos. Chromosome Research: An International Journal on the Molecular Supramolecular and Evolutionary Aspects of Chromosome Biology 14(4): 451-464
Han, M.; Park, D.; Vanderzalm, P.J.; Mains, R.E.; Eipper, B.A.; Taghert, P.H. 2004: Drosophila uses two distinct neuropeptide amidating enzymes, dPAL1 and dPAL2. Journal of Neurochemistry 90(1): 129-141
Cavey, M.; Hijal, S.; Zhang, X.; Suter, B. 2005: Drosophila valois encodes a divergent WD protein that is required for Vasa localization and Oskar protein accumulation. Development 132(3): 459-468
Bier, E.; Bodmer, R. 2004: Drosophila, an emerging model for cardiac disease. Gene 342(1): 1-11
Vodovar, N.; Acosta, C.; Lemaitre, B.; Boccard, F.éd.ér. 2004: Drosophila: a polyvalent model to decipher host-pathogen interactions. Trends in Microbiology 12(5): 235-242
Beppu, K. 2005: Drosophilid faunas in the Akasaka Imperial Gardens and the Tokiwamatsu Imperial Villa, Tokyo. Memoirs of the National Science Museum Tokyo ch; 39: 347-357
Guido, M.; Romualdi, D.; Giuliani, M.; Suriano, R.; Selvaggi, L.; Apa, R.; Lanzone, A. 2004: Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study. Journal of Clinical Endocrinology and Metabolism 89(6): 2817-2823
Czeslick, E.G.; Nestler, F.; Simm, A.; Struppert, A.; Sablotzki, A. 2005: Drotrecogin alfa (activated) does not affect intracellular production of interleukin-6 and tumor necrosis factor-alpha in endotoxin-stimulated human monocytes. Anesthesia and Analgesia 101(6): 1805-1808
Rice, T.W.; Bernard, G.R. 2004: Drotrecogin alfa (activated) for the treatment of severe sepsis and septic shock. American Journal of the Medical Sciences 328(4): 205-214
Brueckmann, M.; Hoffmann, U.; Dvortsak, E.; Lang, S.; Kaden, J.J.; Borggrefe, M.; Haase, K.K. 2004: Drotrecogin alfa (activated) inhibits NF-kappa B activation and MIP-1-alpha release from isolated mononuclear cells of patients with severe sepsis. Inflammation Research: Official Journal of the European Histamine Research Society . 53(10): 528-533
Albuali, W.H.; Singh, R.N.; Fraser, D.D.; Scott, L.A.; Kornecki, A. 2005: Drotrecogin alfa (activated) treatment in a neonate with sepsis and multi organ failure. Saudi Medical Journal 26(8): 1289-1292
Koestenberger, M.; Cvirn, G.; Gallistl, S.; Muntean, W. 2004: Drotrecogin alfa activated (recombinant human activated protein C) in combination with heparin or melagatran: effects on prothrombin time and activated partial thromboplastin time. Blood Coagulation and Fibrinolysis: An International Journal in Haemostasis and Thrombosis 15(8): 693-697
Frommhold, D.; Birle, A.; Linderkamp, O.; Zilow, E.; Pöschl, J. 2005: Drotrecogin alpha (activated) in neonatal septic shock. Scandinavian Journal of Infectious Diseases 37(4): 306-308
Blanco, B., C.; Carrera-Hueso, J.; Poquet-Jornet, J.E.; Martin-Conde, J.A.; Carrera-Hueso, F.J. 2005: Drotrecogina alfa. Atencion Farmaceutica 7(4): 288-295
Aasamaa, K.; Sober, A.; Hartung, W.; Niinemets, U. 2004: Drought acclimation of two deciduous tree species of different layers in a temperate forest canopy. Trees 18(1): 93-101
Hessl, A.E.; Mckenzie, D.; Schellhaas, R. 2004: Drought and Pacific Decadal Oscillation linked to fire occurrence in the inland Pacific Northwest. Ecological Applications 14(2): 425-442
Odebrecht, C.; Abreu, P.; Moller, O.J.; Niencheski, L.; Proenca, L.; Torgan, L. 2005: Drought effects on pelagic properties in the shallow and turbid patos lagoon, Brazil. Estuaries ober; 28(5): 675-685
Yurkonis, K., A.; Meiners, S., J. 2006: Drought impacts and recovery are driven by local variation in species turnover. Plant ecology 184(2): 325-336
Singh, A.K.; Sing, J.; Reddy, K.K.; Singh, R. 2003: Drought proofing mechnism in Mahi command area through linear programming model - A case study. Indian Journal of Agricultural Research 37(3): 187-192
Castillo, E.-Guttierez; Tuong, T.-Phuc; Singh, U.; Inubushi, K.; Padilla, J. 2006: Drought response of dry-seeded rice to water stress timing and N-fertilizer rates and sources. Soil science and plant nutrition 52(4): 496-508
Adams, H.D.; Kolb, T.E. 2004: Drought responses of conifers in ecotone forests of northern Arizona: tree ring growth and leaf sigma13C. Oecologia (Berlin) 140(2): 217-225
Staley, J.-T.M.rtimer, S.-R.M.sters, G.-J.M.recroft, M.-D.B.own, V.-K.T.ylor, M., E. 2006: Drought stress differentially affects leaf-mining species. Ecological entomology 31(5): 460-469
Liu, F.; Jensen, C.R.; Andersen, M.N. 2004: Drought stress effect on carbohydrate concentration in soybean leaves and pods during early reproductive development: Its implication in altering pod set. Field Crops Research 86(1): 1-13, 20 February
Oya, T.; Nepomuceno, A.L.; Neumaier, N.; Farias, J.R. Boucas; Tobita, S.; Ito, O. 2004: Drought tolerance characteristics of Brazilian soybean cultivars - Evaluation and characterization of drought tolerance of various Brazilian soybean cultivars in the field. Plant Production Science 7(2): 129-137
Zeng, H.; Zhong, Y.; Luo, L. 2006: Drought tolerance genes in rice. Functional and Integrative Genomics 6(4): 338-341
Balsamo, R.A.; Willigen, C.V.; Bauer, A.M.; Farrant, J. 2006: Drought tolerance of selected Eragrostis species correlates with leaf tensile properties. Annals of Botany 97(6): 985-991
Li, Y.; Deng, X-Ping.; Kwak, S-Soo.; Tanaka, K. 2006: Drought tolerance of transgenic sweet potato expressing both Cu/Zn superoxide dismutase and ascorbate peroxidase. Zhi Wu Sheng Li Yu Fen Zi Sheng Wu Xue Xue Bao 32(4): 451-457
Acuna-Soto, R.; Stahle, D.W.; Therrell, M.D.; Gomez Chavez, S.; Cleaveland, M.K. 2005: Drought, epidemic disease, and the fall of classic period cultures in Mesoamerica (AD 750-950). Hemorrhagic fevers as a cause of massive population loss. Medical Hypotheses 65(2): 405-409
Silliman, B.R.; van de Koppel, J.; Bertness, M.D.; Stanton, L.E.; Mendelssohn, I.A. 2005: Drought, snails, and large-scale die-off of southern U.S. salt marshes. Science 310(5755): 1803-1806
Shaman, J.; Day, J.F.; Stieglitz, M. 2005: Drought-induced amplification and epidemic transmission of West Nile virus in southern Florida. Journal of Medical Entomology 42(2): 134-141
Morgan, J.W. 2004: Drought-related dieback in four subalpine shrub species, Bogong High Plains, Victoria. Cunninghamia 8(3): 326-330
Gadgil, S.; Vinayachandran, P.N.; Francis, P.A. 2003: Droughts of the Indian summer monsoon: Role of clouds over the Indian Ocean. Current Science 85(12): 1713-1719
Szabadkai, Görgy.; Simoni, A.Maria.; Chami, M.; Wieckowski, M.R.; Youle, R.J.; Rizzuto, R. 2004: Drp-1-dependent division of the mitochondrial network blocks intraorganellar Ca2+ waves and protects against Ca2+-mediated apoptosis. Molecular Cell 16(1): 59-68
Natarajan, P.; Wang, J.; Hua, Z.; Graham, T.R. 2004: Drs2p-coupled aminophospholipid translocase activity in yeast Golgi membranes and relationship to in vivo function. Proceedings of the National Academy of Sciences of the United States of America 101(29): 10614-10619
Zheng, C.J.; Sun, L.Z.; Han, L.Y.; Ji, Z.L.; Chen, X.; Chen, Y.Z. 2004: Drug ADME-associated protein database as a resource for facilitating pharmacogenomics research. Drug Development Research 62(2): 134-142
Gaviraghi, G.; Pellicciari, R. 2004: Drug Discovery: Back and forward. Medicinal Chemistry Research 13(3-4): 216-217
Stewart, K.D.; Shiroda, M.; James, C.A. 2006: Drug Guru: a computer software program for drug design using medicinal chemistry rules. Bioorganic and Medicinal Chemistry 14(20): 7011-7022
Carpenter, K.M.; Schreiber, E.; Church, S.; McDowell, D. 2006: Drug Stroop performance: relationships with primary substance of use and treatment outcome in a drug-dependent outpatient sample. Addictive Behaviors 31(1): 174-181
Kennedy, J.M.; van Rij, A.M. 2006: Drug absorption from the small intestine in immediate postoperative patients. British Journal of Anaesthesia 97(2): 171-180
Gidal, B.E. 2006: Drug absorption in the elderly: biopharmaceutical considerations for the antiepileptic drugs. Epilepsy Research 68(Suppl 1): S65-S69
Silva, O.Alves.; Yonamine, M. 2004: Drug abuse among workers in Brazilian regions. Revista de Saude Publica 38(4): 552-556
Nair, M.P.N.; Schwartz, S.A.; Mahajan, S.D.; Tsiao, C.; Chawda, R.P.; Whitney, R.; Don Sykes, B.B.; Hewitt, R. 2004: Drug abuse and neuropathogenesis of HIV infection: role of DC-SIGN and IDO. Journal of Neuroimmunology 157(1-2): 56-60
Lin, S.K.; Wu, S.H.; Yang, Y.S.; Pan, W.H.T. 2003: Drug addiction-the neurochemical perspective of brain in drug-seeking behavior. Journal of Food and Drug Analysis 11(4): 344-352
Patel, N.C.; Crismon, M.L.; Miller, A.L.; Johnsrud, M.T. 2005: Drug adherence: effects of decreased visit frequency on adherence to clozapine therapy. PharmacoTherapy 25(9): 1242-1247
Collins, G.B.; McAllister, M.S.; Adury, K. 2006: Drug adjuncts for treating alcohol dependence. Cleveland Clinic Journal of Medicine 73(7): 641
Raiman, J.; Hänninen, K.; Kontturi, K.ös.; Murtomäki, L.; Hirvonen, J. 2003: Drug adsorption in human skin: a streaming potential study. Journal of Pharmaceutical Sciences 92(12): 2366-2372
Bertucci, C.; Bartolini, M.; Gotti, R.; Andrisano, V. 2003: Drug affinity to immobilized target bio-polymers by high-performance liquid chromatography and capillary electrophoresis. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 797(1-2): 111-129
Kennedy, J.; Coyne, J.; Sclar, D. 2004: Drug affordability and prescription noncompliance in the United States: 1997-2002. Clinical Therapeutics 26(4): 607-614
Greenberger, P.A. 2006: Drug allergy. Journal of Allergy and Clinical Immunology 117(2, Suppl 1): S464-S470
Walsh, J.M.; Flegel, R.; Atkins, R.; Cangianelli, L.A.; Cooper, C.; Welsh, C.; Kerns, T.J. 2005: Drug and alcohol use among drivers admitted to a Level-1 trauma center. Accident; Analysis and Prevention 37(5): 894-901
Margolese, H.C.; Malchy, L.; Negrete, J.C.; Tempier, R.; Gill, K. 2004: Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research 67(2-3): 157-166
Tardiff, A.Kenneth.J.; Wallace, Z.; Tracy, M.; Piper, T.Markham.; Vlahov, D.; Galea, S. 2005: Drug and alcohol use as determinants of New York City homicide trends from 1990 to 1998. Journal of Forensic Sciences 50(2): 470-474
Furr-Holden, D.; Voas, R.B.; Kelley-Baker, T.; Miller, B. 2006: Drug and alcohol-impaired driving among electronic music dance event attendees. Drug and Alcohol Dependence 85(1): 83-86
Ho, R.H.; Tirona, R.G.; Leake, B.F.; Glaeser, H.; Lee, W.; Lemke, C.J.; Wang, Y.; Kim, R.B. 2006: Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics. Gastroenterology 130(6): 1793-1806
Reiffel, J.A. 2005: Drug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era. Journal of Cardiovascular Pharmacology and Therapeutics 10(Suppl): S45-S58
Xu-Hong-Rong; Li-Xue-Ning; Chen-Wei-Li 2003: Drug approaches to treatment for human immunodeficiency virus infection. Zhongguo Xinyao yu Linchuang Zazhi 22(9): 558-561
Saitoh, Yusuke; Watari, Jiro; Fujiya, Mikihiro; Et-Al 2000: Drug associated enterocolitis: Causative drugs and pathogenesis. Stomach and Intestine 35(9): 1117-1124
Perry, M.; Stansfeld, P.J.; Leaney, J.; Wood, C.; de Groot, M.J.; Leishman, D.; Sutcliffe, M.J.; Mitcheson, J.S. 2005: Drug binding interactions in the inner cavity of HERG channels: molecular insights from structure-activity relationships of clofilium and ibutilide analogs. Molecular Pharmacology 69(2): 509-519
Scholz, E.P.; Zitron, E.; Kiesecker, C.; Lueck, S.; Kathöfer, S.; Thomas, D.; Weretka, S.; Peth, S.; Kreye, V.A.W.; Schoels, W.; Katus, H.A.; Kiehn, J.; Karle, C.A. 2003: Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine. Naunyn-Schmiedeberg's Archives of Pharmacology 368(5): 404-414
Ascoli, G.A.; Domenici, E.; Bertucci, C. 2006: Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality 18(9): 667-679
Li, J.; Xiao, H.; Li, J.; Zhong, Y. 2004: Drug carrier systems based on water-soluble cationic beta-cyclodextrin polymers. International Journal of Pharmaceutics 278(2): 329-342
Himmel, W.; Kochen, M.M.; Sorns, U.; Hummers-Pradier, E. 2004: Drug changes at the interface between primary and secondary care. International Journal of Clinical Pharmacology and Therapeutics 42(2): 103-109
Loboz, K.K.; Shenfield, G.M. 2005: Drug combinations and impaired renal function -- the 'triple whammy'. British Journal of Clinical Pharmacology 59(2): 239-243
Mayor, S. 2005: Drug companies agree to make clinical trial results public. BMJ 330(7483): 109
Cole, J.A.; Norman, H.; Weatherby, L.B.; Walker, A.M. 2006: Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. PharmacoTherapy 26(8): 1157-1164
Vossius, C.; Gjerstad, M.; Baas, H.; Larsen, J.P. 2006: Drug costs for patients with Parkinson's disease in two different European countries. Acta Neurologica Scandinavica 113(4): 228-232
Hyland, A.; Bradford, D.; Gitchell, J. 2005: Drug counselor report of adolescents abuse of nicotine replacement therapy. Journal of Addictive Diseases 24(4): 105-113
Matricardi, P.; Onorati, I.; Coviello, T.; Alhaique, F. 2006: Drug delivery matrices based on scleroglucan/alginate/borax gels. International Journal of Pharmaceutics 316(1-2): 21-28
Donnelly, R.F.; McCarron, P.A.; Woolfson, A.David. 2005: Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy. Photochemistry and Photobiology 81(4): 750-767
Lochmann, D.; Jauk, E.; Zimmer, A. 2004: Drug delivery of oligonucleotides by peptides. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 58(2): 237-251
Liu, X-Ming.; Reinhardt, R.A.; Wang, D. 2006: Drug delivery strategies for common orofacial diseases. Journal of Drug Targeting 14(8): 583-597
Ohki, K. 2006: Drug delivery system (DDS) by use of Liposomes. Membrane 31(1): 38-39
Yoo, J.-W.; Lee, C.H. 2006: Drug delivery systems for hormone therapy. Journal of Controlled Release: Official Journal of the Controlled Release Society 112(1): 1-14
Ameller, T.; Legrand, P.; Marsaud, V.ér.; Renoir, J.-M. 2004: Drug delivery systems for oestrogenic hormones and antagonists: the need for selective targeting in estradiol-dependent cancers. Journal of Steroid Biochemistry and Molecular Biology 92(1-2): 1-18
Allen, T.M.; Cullis, P.R. 2004: Drug delivery systems: entering the mainstream. Science 303(5665): 1818-1822
Simó, C.; Cifuentes, A.; Gallardo, A. 2003: Drug delivery systems: polymers and drugs monitored by capillary electromigration methods. Journal of Chromatography. B Analytical Technologies in the Biomedical and Life Sciences 797(1-2): 37-49
Serafini, S.; Rossi, L.; Antonelli, A.; Fraternale, A.; Cerasi, A.; Crinelli, R.; Chiarantini, L.; Schiavano, G.F.; Magnani, M. 2004: Drug delivery through phagocytosis of red blood cells. Transfusion Medicine and Hemotherapy 31(2): 92-101
Lee, S.-B.; Geroski, D.H.; Prausnitz, M.R.; Edelhauser, H.F. 2004: Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Experimental Eye Research 78(3): 599-607
Vauthier, C.; Dubernet, C.; Chauvierre, C.; Brigger, I.; Couvreur, P. 2003: Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles. Journal of Controlled Release: Official Journal of the Controlled Release Society 93(2): 151-160
Lee, T.Wai-Yip.; Robinson, J.R. 2004: Drug delivery to the posterior segment of the eye II: development and validation of a simple pharmacokinetic model for subconjunctival injection. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 20(1): 43-53
Lee, T.Wai-Yip.; Robinson, J.R. 2004: Drug delivery to the posterior segment of the eye III: the effect of parallel elimination pathway on the vitreous drug level after subconjunctival injection. Journal of Ocular Pharmacology and Therapeutics: the Official Journal of the Association for Ocular Pharmacology and Therapeutics 20(1): 55-64
Reddy, L.H. 2005: Drug delivery to tumours: recent strategies. Journal of Pharmacy and Pharmacology 57(10): 1231-1242
Gerrits, M.A.F.M.; Lesscher, H.B.M.; van Ree, J.M. 2003: Drug dependence and the endogenous opioid system. European Neuropsychopharmacology: the Journal of the European College of Neuropsychopharmacology 13(6): 424-434
Reed, P.L.; Storr, C.L.; Anthony, J.C. 2006: Drug dependence enviromics: job strain in the work environment and risk of becoming drug-dependent. American Journal of Epidemiology 163(5): 404-411
Yamada, K.; Nagai, T.; Nabeshima, T. 2005: Drug dependence, synaptic plasticity, and tissue plasminogen activator. Journal of Pharmacological Sciences 97(2): 157-161
Fujii, H.; Narita, M.; Mizoguchi, H.; Murachi, M.; Tanaka, T.; Kawai, K.; Tseng, L.F.; Nagase, H. 2004: Drug design and synthesis of epsilon opioid receptor agonist: 17-(cyclopropylmethyl)-4,5alpha-epoxy-3,6beta-dihydroxy-6,14-endoethenomorphinan-7alpha-(N-methyl-N-phenethyl)carboxamide (TAN-821) inducing antinociception mediated by putative epsilon opioid receptor. Bioorganic and Medicinal Chemistry 12(15): 4133-4145
Bureeva, S.; Andia-Pravdivy, J.; Kaplun, A. 2005: Drug design using the example of the complement system inhibitors' development. Drug Discovery Today 10(22): 1535-1542
Dikici, E.; Deo, S.K.; Daunert, S. 2003: Drug detection based on the conformational changes of calmodulin and the fluorescence of its enhanced green fluorescent protein fusion partner. Analytica Chimica Acta 500(1-2): 237-245
Freimann, S.; Ben-Ami, I.; Hirsh, L.; Dantes, A.; Halperin, R.; Amsterdam, A. 2004: Drug development for ovarian hyper-stimulation and anti-cancer treatment: blocking of gonadotropin signaling for epiregulin and amphiregulin biosynthesis. Biochemical Pharmacology 68(6): 989-996
Kummar, S.; Gutierrez, M.; Doroshow, J.H.; Murgo, A.J. 2006: Drug development in oncology: classical cytotoxics and molecularly targeted agents. British Journal of Clinical Pharmacology 62(1): 15-26
Triggle, D.J. 2004: Drug development in the 21st century: Medicines, man and receptors. Medicinal Chemistry Research 13(3-4): 238-248
Smith, J.D.; Chakrabarti, E.; Levin-Allerhand, J.A. 2004: Drug discovery: estrogen-related compounds in mouse models of Alzheimer's disease. Journal of Molecular Neuroscience: Mn 24(1): 145-147
Barsby, T. 2006: Drug discovery and sea hares: bigger is better. Trends in Biotechnology 24(1): 1-3
Gullo, V.P.; McAlpine, J.; Lam, K.S.; Baker, D.; Petersen, F. 2006: Drug discovery from natural products. Journal of Industrial Microbiology and Biotechnology 33(7): 523-531
Cuatrecasas, P. 2006: Drug discovery in jeopardy. Journal of Clinical Investigation 116(11): 2837-2842
Workman, P. 2004: Drug discovery strategies: Technologies to accelerate translation from target to drug. Journal of Chemotherapy 16(Suppl 4): 13-15
Davies, S., L.; Silvestre, J., S.; Guitart, X. 2005: Drug discovery targets: 5-HT6 receptor. Drugs of the Future 30(5): 479-495
Ségalat, L. 2006: Drug discovery: here comes the worm. Acs Chemical Biology 1(5): 277-278
Sams-Dodd, F. 2006: Drug discovery: selecting the optimal approach. Drug Discovery Today 11(9-10): 465-472
Zakharova, E.S.; Danysz, W.; Bespalov, A.Y. 2005: Drug discrimination analysis of NMDA receptor channel blockers as nicotinic receptor antagonists in rats. Psychopharmacology 179(1): 128-135
Czoty, P.W.; Ramanathan, C.R.; Mutschler, N.H.; Makriyannis, A.; Bergman, J. 2004: Drug discrimination in methamphetamine-trained monkeys: effects of monoamine transporter inhibitors. Journal of Pharmacology and Experimental Therapeutics 311(2): 720-727
Murav'ev, I.V.; Murav'eva, L.A. 2005: Drug disease: is it iatrogeny?. Terapevticheskii Arkhiv 77(5): 74-76
Källén, A.; Thorsson, L. 2003: Drug disposition analysis: a comparison between budesonide and fluticasone. Journal of Pharmacokinetics and Pharmacodynamics 30(4): 239-256
Srinivas, N.R. 2006: Drug disposition of chiral and achiral drug substrates metabolized by cytochrome P450 2D6 isozyme: case studies, analytical perspectives and developmental implications. Biomedical Chromatography: Bmc 20(6-7): 466-491
Hawkins, M.G.; Karriker, M.J.; Wiebe, V.; Taylor, I.T.; Kass, P.H. 2006: Drug distribution and stability in extemporaneous preparations of meloxicam and carprofen after dilution and suspension at two storage temperatures. Journal of the American Veterinary Medical Association 229(6): 968-974
Li-Yong; Liu-Bin-Wei; Du-Wen-Li; Song-Zhen-Chuan; Zhao-Qun; Fan-Li-Qiao; Yang-Jin-Qiang; Li-Qi-Jun; Wang-Ming-Xia; Jiao-Zhi-Kai; Zhang-Zhi-Dong 2004: Drug distribution in gastric cancer and adjacent tissues by preoperative intraperitoneal chemotherapy with Co-fluorouracil liposome. Zhonghua Zhongliu Zazhi 26(10): 638-640
Van Dijk, E.A.; Drabbe, N.R.G.; Kruijtbosch, M.; De Smet, P.A.G.M. 2006: Drug dosage adjustments according to renal function at hospital discharge. Annals of PharmacoTherapy 40(7-8): 1254-1260
Daschner, M. 2005: Drug dosage in children with reduced renal function. Pediatric Nephrology 20(12): 1675-1686
Yee, T.; Perantie, D.C.; Dhanani, N.; Brown, E.Sherwood. 2004: Drug dreams in outpatients with bipolar disorder and cocaine dependence. Journal of Nervous and Mental Disease 192(3): 238-242
Darke, S.; Kelly, E.; Ross, J. 2004: Drug driving among injecting drug users in Sydney, Australia: prevalence, risk factors and risk perceptions. Addiction 99(2): 175-185
Bachmeier, C.J.; Trickler, W.J.; Miller, D.W. 2004: Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF. Journal of Pharmaceutical Sciences 93(4): 932-942
Presbitero, P.; Boccuzzi, G.; Pagnotta, P. 2005: Drug eluting stents in acute myocardial infarction. Panminerva Medica 47(2): 93-97
Roiron, C.; Sanchez, P.; Bouzamondo, A.; Lechat, P.; Montalescot, G. 2006: Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92(5): 641-649
Chattopadhyay, P.; Huff, R.; Shekunov, B.Y. 2006: Drug encapsulation using supercritical fluid extraction of emulsions. Journal of Pharmaceutical Sciences 95(3): 667-679
Yilmaz, E.; Bengisu, M. 2006: Drug entrapment in silica microspheres through a single step sol-gel process and in vitro release behavior. Journal of Biomedical Materials Research. Part B Applied Biomaterials 77(1): 149-155
Rallis, E.; Balatsouras, D.G.; Kouskoukis, C.; Verros, C.; Homsioglou, E. 2006: Drug eruptions in children with ENT infections. International Journal of Pediatric Otorhinolaryngology 70(1): 53-57
Lazar, C.; Kluczyk, A.; Kiyota, T.; Konishi, Y. 2004: Drug evolution concept in drug design: 1. Hybridization method. Journal of Medicinal Chemistry 47(27): 6973-6982
Hogarth, L.; Dickinson, A.; Hutton, S.B.; Elbers, N.; Duka, T. 2006: Drug expectancy is necessary for stimulus control of human attention, instrumental drug-seeking behaviour and subjective pleasure. Psychopharmacology 185(4): 495-504
Czeizel, A.E. 2004: Drug exposure in pregnant women. Lupus 13(9): 740-745
Re, M.C.; Bon, I.; Monari, P.; Gorini, R.; Schiavone, P.; Gibellini, D.; La Placa, M. 2003: Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance. New Microbiologica 26(4): 405-413
Wakonigg, G.; Sturm, K.; Saria, A.; Zernig, G. 2004: Drug history overrides opioid reinforcement in a rat runway procedure. Pharmacology 72(4): 225-230
Kim, C-Woo.; Choi, G-Seong.; Yun, C-Ho.; Kim, D-In. 2006: Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome. Journal of Korean Medical Science 21(4): 768-772
Shinar, D.; Schechtman, E. 2005: Drug identification performance on the basis of observable signs and symptoms. Accident; Analysis and Prevention 37(5): 843-851
Yap, Y.G.; Camm, A.J. 2003: Drug induced QT prolongation and torsades de pointes. Heart 89(11): 1363-1372
Chazan, B.; Weiss, A.; Weiner, Z.; Rimbrot, S.; Raz, R. 2003: Drug induced aseptic meningitis due to diclofenac. Journal of Neurology 250(12): 1503-1504
Latour, P.; Biraben, A.; Polard, E.; Bentué-Ferrer, D.èl.; Beauplet, A.; Tribut, O.; Allain, H.é 2004: Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?. Human Psychopharmacology 19(3): 193-203
Bazlul Karim, A.S.M.; Hoque, M.Shafiqul.; Kamal, M. 2004: Drug induced hepatic focal nodular hyperplasia. Indian Journal of Pediatrics 71(11): 1025-1027
Hirose, G. 2006: Drug induced parkinsonism - A review. Journal of Neurology 253(Suppl 3): 22-24
Masruha, M.R.; Marques, C.M.; Vilanova, L.C.P.; de Seixas Alves, M.T.; Peres, M.F.P.; Rodrigues, M.G. 2005: Drug induced pseudolymphoma secondary to ethosuximide. Journal of Neurology Neurosurgery and Psychiatry 76(11): 1610
Singh, J. 2004: Drug info zone. Indian Journal of Pharmacology 36(5): 334-335
Crank, M.Y. 2005: Drug information services: Hospital pharmacists' utilisation and opinion. Journal of Pharmacy Practice and Research 35(4): 284-286
Bouhnik, A.-D.éb.; Carrieri, M.P.; Rey, D.; Spire, B.; Gastaut, J.-A.; Gallais, H.é; Obadia, Y. 2004: Drug injection cessation among HIV-infected injecting drug users. Addictive Behaviors 29(6): 1189-1197
Booth, R.E.; Kennedy, J.; Brewster, T.; Semerik, O. 2003: Drug injectors and dealers in Odessa, Ukraine. Journal of Psychoactive Drugs 35(4): 419-426
Aadil, N.; Houti, I.E.; Moussamih, S. 2004: Drug intake during Ramadan. BMJ 329(7469): 778-782
El Maghraby, G.M.M.; Williams, A.C.; Barry, B.W. 2005: Drug interaction and location in liposomes: correlation with polar surface areas. International Journal of Pharmaceutics 292(1-2): 179-185
Yildirim, Y.; Ozyilkan, O.; Akcali, Z.; Basturk, B. 2006: Drug interaction between capecitabine and warfarin: a case report and review of the literature. International Journal of Clinical Pharmacology and Therapeutics 44(2): 80-82
Onoda, S.; Mitsufuji, H.; Yanase, N.; Ryuge, S.; Kato, E.; Wada, M.; Ishii, K.; Hagiri, S.; Yamamoto, M.; Yokoba, M.; Yanaihara, T.; Kuboto, M.; Takada, N.; Katagiri, M.; Abe, T.; Tanaka, N.; Kobayashi, H.; Masuda, N. 2005: Drug interaction between gefitinib and warfarin. Japanese Journal of Clinical Oncology 35(8): 478-482
Roblin, X.; Serre-Debeauvais, F.; Phelip, J-M.; Bessard, G.; Bonaz, B. 2003: Drug interaction between infliximab and azathioprine in patients with Crohn's disease. Alimentary Pharmacology and Therapeutics 18(9): 917-925
Okuda, T.; Ito, Y.; Nakagawa, N.; Hishinuma, T.; Tsukamoto, H.; Iwabuchi, K.; Watanabe, T.; Kitaichi, K.; Goto, J.; Yanai, K. 2004: Drug interaction between methamphetamine and antihistamines: behavioral changes and tissue concentrations of methamphetamine in rats. European Journal of Pharmacology 505(1-3): 135-144
Kuypers, D.R.J.; Verleden, G.; Naesens, M.; Vanrenterghem, Y. 2005: Drug interaction between mycophenolate mofetil and rifampin: possible induction of uridine diphosphate-glucuronosyltransferase. Clinical Pharmacology and Therapeutics 78(1): 81-88
Guillen-Anaya, M-Angel.; Jadoul, M. 2004: Drug interaction between sevelamer and cyclosporin. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 19(2): 515
Fleuren, H.W.H.A.; Kho, Y.; Schuurmans, M.M.J.; Vollaard, E.J. 2005: Drug interaction between sevelamer and furosemide. Nephrology Dialysis Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 20(10): 2288-2289
Depta, J.Paul.Heribert.; Altznauer, F.; Gamerdinger, K.; Burkhart, C.; Weltzien, H.Ulrich.; Pichler, W.Joseph. 2004: Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. Journal of Allergy and Clinical Immunology 113(3): 519-527
Alisky, J.M.; Chertkova, E.L.; Iczkowski, K.A. 2006: Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis. Medical Hypotheses 67(5): 1090-1094
Gasse, C.; Hollowell, J.; Meier, C.R.; Haefeli, W.E. 2005: Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thrombosis and Haemostasis 94(3): 537-543
Reimers, A.; Skogvoll, E.; Sund, J.Kutschera.; Spigset, O. 2005: Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service. Journal of Clinical Psychopharmacology 25(4): 342-348
Clark, D.B.; Andrus, M.R.; Byrd, D.C. 2006: Drug interactions between linezolid and selective serotonin reuptake inhibitors: case report involving sertraline and review of the literature. PharmacoTherapy 26(2): 269-276
Hersh, E.V.; Moore, P.A. 2004: Drug interactions in dentistry: the importance of knowing your CYPs. Journal of the American Dental Association 135(3): 298-311
Bergk, V.; Gasse, C.; Rothenbacher, D.; Loew, M.; Brenner, H.; Haefeli, W.E. 2004: Drug interactions in primary care: impact of a new algorithm on risk determination. Clinical Pharmacology and Therapeutics 76(1): 85-96
Tirkkonen, T.; Laine, K. 2004: Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients. Clinical Pharmacology and Therapeutics 76(6): 639-647
Berkowitz, B.A.; Roberts, R.; Luan, H.; Peysakhov, J.; Knoerzer, D.L.; Connor, J.R.; Hohman, T.C. 2005: Drug intervention can correct subnormal retinal oxygenation response in experimental diabetic retinopathy. Investigative Ophthalmology and Visual Science 46(8): 2954-2960
Murdoch, J.A.C.; Lane, J.; Goldstein, D.H. 2004: Drug labelling and a near miss in the labour suite. Canadian Journal of Anaesthesia 51(8): 854-855
Lewis, A.L.; Willis, S.L.; Small, S.A.; Hunt, S.R.; O'byrne, V.; Stratford, P.W. 2004: Drug loading and elution from a phosphorylcholine polymer-coated coronary stent does not affect long-term stability of the coating in vivo. Bio-Medical Materials and Engineering 14(4): 355-370
Abdekhodaie, M.J.; Wu, X.Y. 2006: Drug loading onto ion-exchange microspheres: modeling study and experimental verification. Biomaterials 27(19): 3652-3662
Stumpf, W.E. 2005: Drug localization and targeting with receptor microscopic autoradiography. Journal of Pharmacological and Toxicological Methods 51(1): 25-40
Ponsoda, X.; Donato, M.Teresa.; Perez-Cataldo, G.; Gómez-Lechón, M.José.; Castell, Jé.V. 2004: Drug metabolism by cultured human hepatocytes: how far are we from the in vivo reality?. Alternatives to Laboratory Animals: Atla 32(2): 101-110
Kermode-Scott, B. 2004: Drug misuse in Canada has increased in the past decade. Bmj 329(7478): 1304
Gerada, C. 2005: Drug misuse: a review of treatments. Clinical Medicine 5(1): 69-73
Hägerström, H.; Strømme, M.; Edsman, K. 2005: Drug molecules as probes for studying the compatibility between gels and mucous tissue with dielectric spectroscopy. Journal of Pharmaceutical Sciences 94(5): 1090-1100
Lee, J. 2003: Drug nano- and microparticles processed into solid dosage forms: physical properties. Journal of Pharmaceutical Sciences 92(10): 2057-2068
Keck, C.M.; Müller, R.H. 2006: Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 62(1): 3-16
Moribe, K.; Pongpeerapat, A.; Tozuka, Y.; Yamamoto, K. 2006: Drug nanoparticle formation from drug/HPMC/SDS ternary ground mixtures. Die Pharmazie 61(2): 97-101
Bossert, J.M.; Shaham, Y. 2004: Drug onset cues, conditioned withdrawal, and drug relapse: comment on McDonald and Siegel (2004). Experimental and Clinical Psychopharmacology 12(1): 15-7; Discussion 23-6
Engvall, C.; Lundahl, P. 2004: Drug partition chromatography on immobilized porcine intestinal brush border membranes. Journal of Chromatography A 1031(1-2): 107-112
Barbaud, A. 2005: Drug patch testing in systemic cutaneous drug allergy. Toxicology 209(2): 209-216
Oldman, M.; Moore, D.; Collins, S. 2004: Drug patient information leaflets in anaesthesia: effect on anxiety and patient satisfaction. British Journal of Anaesthesia 92(6): 854-858
Flaten, G.ør.E.; Dhanikula, A.B.; Luthman, K.; Brandl, M. 2006: Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 27(1): 80-90
Flaten, G.ør.E.; Bunjes, H.; Luthman, K.; Brandl, M. 2006: Drug permeability across a phospholipid vesicle-based barrier 2. Characterization of barrier structure, storage stability and stability towards pH changes. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 28(4): 336-343
Mälkiä, A.; Murtomäki, L.; Urtti, A.; Kontturi, K.ös. 2004: Drug permeation in biomembranes: in vitro and in silico prediction and influence of physicochemical properties. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 23(1): 13-47
Suvarna, R.; Pirmohamed, M.; Henderson, L. 2003: Drug point: Possible interaction between warfarin and cranberry juice. BMJ 327(7429): 1454
Waage, I.-Marie; Gedde-Dahl, A. 2003: Drug points: Pulmonary embolism possibly associated with olanzapine treatment. BMJ 327(7428): 1384
Morton, A.; Muir, J.; Lim, D. 2004: Drug points: Rash and acute nephritic syndrome due to candesartan. BMJ 328(7430): 25
Shotar, A.M. 2005: Drug poisoning in childhood. Saudi Medical Journal 26(12): 1948-1950
Marlowe, D.B.; Elwork, A.; Festinger, D.S.; McLellan, A.Thomas. 2003: Drug policy by popular referendum: This, too, shall pass. Journal of Substance Abuse Treatment 25(3): 213-221
Maseeh, A.; Dadhich, A.P.; Agarwal, A.K. 2004: Drug prescribing pattern in patients admitted with tuberculosis in a tertiary care hospital. Asia Pacific Journal of Pharmacology 16(2): 49-52
Vedsted, P.; Sørensen, H.Toft.; Mortensen, J.Tølbøll. 2004: Drug prescription for adult frequent attenders in Danish general practice: a population-based study. Pharmacoepidemiology and Drug Safety 13(10): 717-724
Egen-Lappe, V.; Hasford, J. 2004: Drug prescription in pregnancy: analysis of a large statutory sickness fund population. European Journal of Clinical Pharmacology 60(9): 659-666
Bongard, V.; Grenier, O.; Ferrières, J.; Danchin, N.; Cantet, C.; Amelineau, E.; Cambou, J-Pierre. 2004: Drug prescriptions and referral to cardiac rehabilitation after acute coronary events: comparison between men and women in the French PREVENIR Survey. International Journal of Cardiology 93(2-3): 217-223
Gorniak, J.M.; Jenkins, A.J.; Felo, J.A.; Balraj, E. 2005: Drug prevalence in drowning deaths in Cuyahoga County, Ohio: a ten-year retrospective study. American Journal of Forensic Medicine and Pathology 26(3): 240-243
Messaad, D.; Sahla, H.; Benahmed, S.; Godard, P.; Bousquet, J.; Demoly, P. 2004: Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Annals of Internal Medicine 140(12): 1001-1006
Khabriyev, R.U.; Yagudina, R.I. 2005: Drug quality on the Russian pharmaceutical market: general trends. Farmatsiya (Moscow) (4): 22-24
DeMaria, A.N. 2004: Drug reimportation: sitting in the middle. Journal of the American College of Cardiology 43(1): 149-150
Watson, R. 2004: Drug related deaths in Europe are falling. BMJ 329(7478): 1304
Souchet, E.; Lapeyre-Mestre, M.; Montastruc, J.-L. 2005: Drug related falls: a study in the French Pharmacovigilance database. Pharmacoepidemiology and Drug Safety 14(1): 11-16
Friedrich, I.; Reichl, S.; Müller-Goymann, C.C. 2005: Drug release and permeation studies of nanosuspensions based on solidified reverse micellar solutions (SRMS). International Journal of Pharmaceutics 305(1-2): 167-175
Matsumoto, A.; Matsukawa, Y.; Suzuki, T.; Yoshino, H. 2005: Drug release characteristics of multi-reservoir type microspheres with poly(dl-lactide-co-glycolide) and poly(dl-lactide). Journal of Controlled Release: Official Journal of the Controlled Release Society 106(1-2): 172-180
Lou, X.; Munro, S.; Wang, S. 2004: Drug release characteristics of phase separation pHEMA sponge materials. Biomaterials 25(20): 5071-5080
Pitarresi, G.; Pierro, P.; Giammona, G.; Iemma, F.; Muzzalupo, R.; Picci, N. 2004: Drug release from alpha,beta-poly(N-2-hydroxyethyl)-DL-aspartamide-based microparticles. Biomaterials 25(18): 4333-4343
Llabot, J.M.; Manzo, R.H.; Allemandi, D.A. 2004: Drug release from carbomer:carbomer sodium salt matrices with potential use as mucoadhesive drug delivery system. International Journal of Pharmaceutics 276(1-2): 59-66
Cornejo-Bravo, J.M.; Flores-Guillen, M.E.; Lugo-Medina, E.; Licea-Claverie, A. 2005: Drug release from complexes with a series of poly(carboxyalkyl methacrylates), a new class of weak polyelectrolytes. International Journal of Pharmaceutics 305(1-2): 52-60
Tada, D.; Tanabe, T.; Tachibana, A.; Yamauchi, K. 2005: Drug release from hydrogel containing albumin as crosslinker. Journal of Bioscience and Bioengineering 100(5): 551-555
Wang, L.; Venkatraman, S.; Kleiner, L. 2004: Drug release from injectable depots: two different in vitro mechanisms. Journal of Controlled Release: Official Journal of the Controlled Release Society 99(2): 207-216
Guse, C.; Koennings, S.; Kreye, F.; Siepmann, F.; Goepferich, A.; Siepmann, J. 2006: Drug release from lipid-based implants: elucidation of the underlying mass transport mechanisms. International Journal of Pharmaceutics 314(2): 137-144
Kondyurin, A.V.; Maitz, M.F.; Romanova, V.A.; Begishev, V.P.; Kondyurina, I.V.; Guenzel, R. 2004: Drug release from polyureaurethane coating modified by plasma immersion ion implantation. Journal of Biomaterials Science. Polymer Edition 15(2): 145-159
Tunón, A.; Börjesson, E.; Frenning, Göran.; Alderborn, Göran. 2003: Drug release from reservoir pellets compacted with some excipients of different physical properties. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 20(4-5): 469-479
Tuovinen, L.; Peltonen, S.; Järvinen, K. 2003: Drug release from starch-acetate films. Journal of Controlled Release: Official Journal of the Controlled Release Society 91(3): 345-354
Tuovinen, L.; Peltonen, S.; Liikola, M.; Hotakainen, M.; Lahtela-Kakkonen, M.; Poso, A.; Järvinen, K. 2004: Drug release from starch-acetate microparticles and films with and without incorporated alpha-amylase. Biomaterials 25(18): 4355-4362
Kiortsis, S.; Kachrimanis, K.; Broussali, T.; Malamataris, S. 2005: Drug release from tableted wet granulations comprising cellulosic (HPMC or HPC) and hydrophobic component. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 59(1): 73-83
Kim, I-Sook.; Oh, I-Joon. 2005: Drug release from the enzyme-degradable and pH-sensitive hydrogel composed of glycidyl methacrylate dextran and poly(acrylic acid). Archives of Pharmacal Research 28(8): 983-987
Yoo, M.Kyong.; Choi, H.Kyun.; Kim, T.Hee.; Choi, Y.Jaie.; Akaike, T.; Shirakawa, M.; Cho, C.Su. 2005: Drug release from xyloglucan beads coated with Eudragit for oral drug delivery. Archives of Pharmacal Research 28(6): 736-742
Ferrero, C.; Bravo, I.; Jiménez-Castellanos, M.R. 2003: Drug release kinetics and fronts movement studies from methyl methacrylate (MMA) copolymer matrix tablets: effect of copolymer type and matrix porosity. Journal of Controlled Release: Official Journal of the Controlled Release Society 92(1-2): 69-82
Zhang, L.; Chen, D-wei.; Gao, Z-bin. 2006: Drug release mechanism of famotidine time-controlled release pellets. Yao Xue Xue Bao 41(9): 873-877
Abu-Bakr, M.; Khatun, S.; Islam, M.-Amirul 2004: Drug release profile of malic acid-phthalic acid butane 1,4-diol copolyester. Pakistan Journal of Scientific and Industrial Research 47(4): 251-255
Charrois, G.J.R.; Allen, T.M. 2004: Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochimica et Biophysica Acta 1663(1-2): 167-177
Ongerth, J.E.; Khan, S. 2004: Drug residuals: How xenobiotics can affect water supply sources. Journal - American Water Works Association 96(5): 94-101
Shafer, R.W.; Schapiro, J.M. 2005: Drug resistance and antiretroviral drug development. Journal of Antimicrobial ChemoTherapy 55(6): 817-820
Casanovas, O.; Hicklin, D.J.; Bergers, G.; Hanahan, D. 2005: Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 8(4): 299-309
Smith, R.J.; Wahl, L.M. 2005: Drug resistance in an immunological model of HIV-1 infection with impulsive drug effects. Bulletin of Mathematical Biology 67(4): 783-813
Komarova, N.L.; Wodarz, D. 2005: Drug resistance in cancer: principles of emergence and prevention. Proceedings of the National Academy of Sciences of the United States of America 102(27): 9714-9719
Saeki, T.; Tsuruo, T.; Sato, W.; Nishikawsa, K. 2005: Drug resistance in chemotherapy for breast cancer. Cancer ChemoTherapy and Pharmacology 56(Suppl 1): 84-89
Schmidt, D.; Löscher, W. 2005: Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46(6): 858-877
Boost, M.; Lai, L.; O'Donoghue, M. 2004: Drug resistance in fecal enterococci in Hong Kong. Journal of Infection and Chemotherapy: Official Journal of the Japan Society of ChemoTherapy 10(6): 326-330
Ebrahim, G.J. 2007: Drug resistance in tuberculosis. Journal of Tropical Pediatrics 53(3): 147-149
Paramasivan, C.N.; Venkataraman, P. 2004: Drug resistance in tuberculosis in India. Indian Journal of Medical Research 120(4): 377-386
Larbalestier, N.; Mullen, J.; O'Shea, S.; Cottam, F.; Sabin, C.A.; Chrystie, I.L.; Welch, J.; Zuckerman, M.; Hay, P.; Rice, P.; Taylor, G.P.; de Ruiter, A. 2003: Drug resistance is uncommon in pregnant women with low viral loads taking zidovudine monotherapy to prevent perinatal HIV transmission. Aids 17(18): 2665-2667
Torti, C.; Quiros-Roldan, E.; Monno, L.; Patroni, A.; Saracino, A.; Angarano, G.; Tinelli, C.; Lo Caputo, S.; Tirelli, V.; Mazzotta, F.; Carosi, G. 2004: Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. Journal of Medical Virology 74(1): 29-33
Crespan, E.; Locatelli, G.A.; Cancio, R.; Hübscher, U.; Spadari, S.; Maga, G. 2005: Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz. Antimicrobial Agents and ChemoTherapy 49(1): 342-349
Anokhin, V.A.; Khaliullina, S.V.; Khasanova, E.E.; Nikolaeva, I.V.; Malysheva, L.M.; Gerasimova, E.S. 2005: Drug resistance of Esherichia coli in asymptomatic bacteriuria and bacteriolactia. Kazanskii Meditsinskii Zhurnal 86(3): 191-194
Bandyopadhyay, P.; Meher, B.R. 2006: Drug resistance of HIV-1 protease against JE-2147: I47V mutation investigated by molecular dynamics simulation. Chemical Biology and Drug Design 67(2): 155-161
Liu, C-Eng.; Chen, C.-Hua.; Hsiao, J-Hua.; Young, T-Guang.; Tsay, R-Wen.; Fung, C-Phone. 2004: Drug resistance of Mycobacterium tuberculosis complex in central Taiwan. Journal of Microbiology Immunology and Infection 37(5): 295-300
Nian, H. Wang, Q. Sun, Y.H.; Ding, L.P. 2004: Drug resistance of common bacteria isolated from blood and bone marrow. Journal of China Medical University 33(1): 83-85
Yang-Ri-Dong; Li-Xiao-Dong; Tao-Xiao-Hua; Cai-Chuan-Chuan; Zhang-Wen-Jun; Lin-Shi-Ying; Chen-Zhan-Lin 2004: Drug resistance of fungi in EPS of patients with prostatitis post-STD. Zhongguo Kangshengsu Zazhi 29(6): 378-380
Liaw, Y-Shuang.; Hsueh, P-Ren.; Yu, C-Jen.; Wang, S-Kuang.; Yang, P-Chyr.; Luh, K-Tay. 2004: Drug resistance pattern of Mycobacterium tuberculosis in a university hospital in Taiwan, 1998-2002. Journal of the Formosan Medical Association 103(9): 671-677
Pereira, M.; Tripathy, S.; Inamdar, V.; Ramesh, K.; Bhavsar, M.; Date, A.; Iyyer, R.; Acchammachary, A.; Mehendale, S.; Risbud, A. 2005: Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian Journal of Medical Research 121(4): 235-239
Quan, Y.; Brenner, B.G.; Marlink, R.G.; Essex, M.; Kurimura, T.; Wainberg, M.A. 2003: Drug resistance profiles of recombinant reverse transcriptases from human immunodeficiency virus type 1 subtypes A/E, B, and C. Aids Research and Human Retroviruses 19(9): 743-753
Gómez-Carrillo, M.; Quarleri, J.F.; Rubio, A.E.; Carobene, M.G.; Dilernia, D.ío.; Carr, J.K.; Salomón, H. 2004: Drug resistance testing provides evidence of the globalization of HIV type 1: a new circulating recombinant form. Aids Research and Human Retroviruses 20(8): 885-888
Hinrichs, J.W.J.; Klappe, K.; van Riezen, M.; Kok, J.W. 2005: Drug resistance-associated changes in sphingolipids and ABC transporters occur in different regions of membrane domains. Journal of Lipid Research 46(11): 2367-2376
Waller, P.C.; Evans, S.J.W.; Beard, K. 2006: Drug safety and the media. British Journal of Clinical Pharmacology 61(2): 123-126
Juillerat, P.; Felley, C.; Mottet, C.; Froehlich, F.; Vader, J-Paul.; Burnand, B.; Gonvers, J-Jacques.; Michetti, P. 2005: Drug safety in the treatment of Crohn's disease. Digestion 71(1): 8-12
Lu, N.T.; Taylor, B.G. 2006: Drug screening and confirmation by GC-MS: comparison of EMIT Ii and Online KIMS against 10 drugs between US and England laboratories. Forensic Science International 157(2-3): 106-116
Liu, A.; Cao, H.; Du, G. 2005: Drug screening for influenza neuraminidase inhibitors. Science in China. Series C Life Sciences 48(1): 1-5
Schwettmann, L.; Külpmann, W-Rüdiger.; Vidal, C. 2006: Drug screening in urine by cloned enzyme donor immunoassay (CEDIA) and kinetic interaction of microparticles in solution (KIMS): a comparative study. Clinical Chemistry and Laboratory Medicine 44(4): 479-487
Altun, Z.; Blomberg, L., G.; Jagerdeo, E.; Abdel-Rehim, M. 2006: Drug screening using microextraction in a packed syringe (MEPS)/mass spectrometry utilizing monolithic-, polymer-, and silica-based sorbents. Journal of Liquid Chromatography and Related Technologies 29(6): 829-840
Vanderschuren, L.J.M.J.; Everitt, B.J. 2004: Drug seeking becomes compulsive after prolonged cocaine self-administration. Science 305(5686): 1017-1019
Vukmir, R.B. 2004: Drug seeking behavior. American Journal of Drug and Alcohol Abuse 30(3): 551-575
Tomson, Törn. 2004: Drug selection for the newly diagnosed patient: when is a new generation antiepileptic drug indicated?. Journal of Neurology 251(9): 1043-1049
Matsuo, Y.; Kakimaru, A.; Miyazaki, D.; Hatta, S.; Inoue, Y.; Fujiwara, H. 2005: Drug sensitivity and patients' background of isolated microorganisms in our institution. Rinsho Ganka 59(6): 886-890
Attlmayr, B.; Kollaritsch, H.; Wernsdorfer, W.H.; Miller, R.S.; Sirichaisinthop, J.; Noedl, H. 2006: Drug sensitivity of Plasmodium falciparum along the Thai-Myanmar border using the new field-deployable HRP2 in vitro assay. Wiener Klinische Wochenschrift 117(Suppl): 35-38
Shman, T.V.; Belevtsev, M.B.; Buglova, S.Y. 2005: Drug sensitivity of tumor cells in varieties of acute childhood leukemia. Voprosy Onkologii (Stsburg). 51(5): 558-562
Isonishi, S.; Niimi, S.; Sasaki, H.; Ochiai, K.; Yasuda, M.; Tanaka, T. 2004: Drug sensitivity-related benefit of systematic lymphadenectomy during cytoreductive surgery in optimally debulked stages IIIc and IV ovarian cancer. Gynecologic Oncology 93(3): 647-652
Barbaud, A.; Trechot, P.; Weber-Muller, F.; Ulrich, G.; Commun, N.; Schmutz, J.L. 2004: Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins. Contact Dermatitis 50(1): 22-26
McDermott, Sán.D.; Power, J.D. 2005: Drug smuggling using clothing impregnated with cocaine. Journal of Forensic Sciences 50(6): 1423-1425
Kaukonen, A.Marie.; Boyd, B.J.; Porter, C.J.H.; Charman, W.N. 2004: Drug solubilization behavior during in vitro digestion of simple triglyceride lipid solution formulations. Pharmaceutical Research 21(2): 245-253
Kaukonen, A.Marie.; Boyd, B.J.; Charman, W.N.; Porter, C.J.H. 2004: Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids. Pharmaceutical Research 21(2): 254-260
Müller, J.; Lips, K.S.; Metzner, L.; Neubert, R.H.H.; Koepsell, H.; Brandsch, M. 2005: Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochemical Pharmacology 70(12): 1851-1860
Linde, L.; Hetland, M.L.; Ostergaard, M. 2006: Drug survival and reasons for discontinuation of intramuscular methotrexate: a study of 212 consecutive patients switching from oral methotrexate. Scandinavian Journal of Rheumatology 35(2): 102-106
Ehara, M.; Nguyen, B.M.; Nguyen, D.T.; Toma, C.; Higa, N.; Iwanaga, M. 2004: Drug susceptibility and its genetic basis in epidemic Vibrio cholerae O1 in Vietnam. Epidemiology and Infection 132(4): 595-600
Sethi, S.; Sharma, S.; Sharma, S.K.; Meharwal, S.K.; Jindal, S.K.; Sharma, M. 2004: Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Indian Journal of Medical Research 120(5): 468-471
Coban, A.Y.; Birinci, A.; Ekinci, B.; Durupinar, B. 2004: Drug susceptibility testing of Mycobacterium tuberculosis by the broth microdilution method with 7H9 broth. Memorias do Instituto Oswaldo Cruz 99(1): 111-113
Coban, A.Y.; Birinci, A.; Ekinci, B.; Durupinar, B. 2004: Drug susceptibility testing of Mycobacterium tuberculosis with nitrate reductase assay. International Journal of Antimicrobial Agents 24(3): 304-306
Zhao, S.Z.; Wentworth, C.; Burke, T.A.; Makuch, R.W. 2004: Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs. Pharmacoepidemiology and Drug Safety 13(5): 277-287
Li, T.-K.; Barbieri, C.M.; Lin, H.-C.; Rabson, A.B.; Yang, G.; Fan, Y.; Gaffney, B.L.; Jones, R.A.; Pilch, D.S. 2004: Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication. Biochemistry 43(30): 9732-9742
Harsha, N.Sree.; Rani, R.H.Shobha. 2006: Drug targeting to lungs by way of microspheres. Archives of Pharmacal Research 29(7): 598-604
Fendrich, M.; Johnson, T.P.; Wislar, J.S.; Hubbell, A. 2004: Drug test feasibility in a general population household survey. Drug and Alcohol Dependence 73(3): 237-250
Peters, F.T.; Samyn, N.; Lamers, C.T.J.; Riedel, W.J.; Kraemer, T.; de Boeck, G.; Maurer, H.H. 2005: Drug testing in blood: validated negative-ion chemical ionization gas chromatographic-mass spectrometric assay for enantioselective measurement of the designer drugs MDEA, MDMA, and MDA and its application to samples from a controlled study with MDMA. Clinical Chemistry 51(10): 1811-1822
Levy, S.; Harris, S.Kim.; Sherritt, L.; Angulo, M.; Knight, J.R. 2006: Drug testing of adolescents in ambulatory medicine: physician practices and knowledge. Archives of Pediatrics and Adolescent Medicine 160(2): 146-150
Tallman, M.S.; Gilliland, D.Gary.; Rowe, J.M. 2005: Drug therapy for acute myeloid leukemia. Blood 106(4): 1154-1163
Kumar, R.; Gautam, G.; Gupta, N.P. 2006: Drug therapy for idiopathic male infertility: rationale versus evidence. Journal of Urology 176(4 Part 1): 1307-1312
Winocour, P.H. 2005: Drug therapy for prevention of cardiovascular disease--should surrogate measures be abandoned?. Clinical Medicine 5(3): 282-6; discussion 287-8
Abdulla, R-id. 2005: Drug therapy in pediatric cardiology and the role of digoxin in pediatric congestive heart failure. Pediatric Cardiology 25(6): 621
Lindenfeld, J.; Miller, G.G.; Shakar, S.F.; Zolty, R.; Lowes, B.D.; Wolfel, E.E.; Mestroni, L.; Page, R.L.; Kobashigawa, J. 2004: Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation 110(24): 3734-3740
Lindenfeld, J.; Miller, G.G.; Shakar, S.F.; Zolty, R.; Lowes, B.D.; Wolfel, E.E.; Mestroni, L.; Page, R.L.; Kobashigawa, J. 2004: Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation 110(25): 3858-3865
Lindenfeld, J.; Page, R.L.; Zolty, R.; Shakar, S.F.; Levi, M.; Lowes, B.; Wolfel, E.E.; Miller, G.G. 2005: Drug therapy in the heart transplant recipient: Part III: common medical problems. Circulation 111(1): 113-117
Page, R.L.; Miller, G.G.; Lindenfeld, J. 2005: Drug therapy in the heart transplant recipient: part IV: drug-drug interactions. Circulation 111(2): 230-239
Marković, B.Bergman.; Kranjcević, K.; Reiner, Z.; Blazeković, S.Milaković.; Spehar, S.Stojanović. 2005: Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service. Croatian Medical Journal 46(6): 984-989
Chen, D-you.; Cao, J.; Zhu, B-po. 2006: Drug therapy of paroxysmal atrial fibrillation in the elderly over 75 years old. Chinese Medical Sciences Journal 21(1): 16-19
Howard, P.A.; Cheng, J.W.M.; Crouch, M.A.; Colucci, V.J.; Kalus, J.S.; Spinler, S.A.; Munger, M. 2006: Drug therapy recommendations from the 2005 ACC/AHA guidelines for treatment of chronic heart failure. Annals of pharmacotherapy 40(9): 1607-1617
McIntyre, J.; Choonara, I. 2004: Drug toxicity in the neonate. Biology of the Neonate 86(4): 218-221
Serra, L.; Doménech, J.; Peppas, N.A. 2006: Drug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogels. Biomaterials 27(31): 5440-5451
Mottier, L.; Alvarez, L.; Ceballos, L.; Lanusse, C. 2006: Drug transport mechanisms in helminth parasites: passive diffusion of benzimidazole anthelmintics. Experimental Parasitology 113(1): 49-57
Petzinger, E.; Geyer, J. 2006: Drug transporters in pharmacokinetics. Naunyn-Schmiedeberg's Archives of Pharmacology 372(6): 465-475
Walsh, J.M.E.; Pignone, M. 2004: Drug treatment of hyperlipidemia in women. JAMA 291(18): 2243-2252
Dai-Yongan; Chen-Tielong; Luo-Mingqi; Et-Al 2005: Drug treatment of opportunistic infections in 53 patients with AIDS. Wuhan Daxue Xuebao (Yixue Ban) 26(6): 755-757
Beaulieu, M-D.; Brophy, J.; Jacques, A.; Blais, R.; Battista, R.; Lebeau, R. 2004: Drug treatment of stable angina pectoris and mass dissemination of therapeutic guidelines: a randomized controlled trial. Qjm: Monthly Journal of the Association of Physicians 97(1): 21-31
Bhattacharjee, H.; Carbrey, J.; Rosen, B.P.; Mukhopadhyay, R. 2004: Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9. Biochemical and Biophysical Research Communications 322(3): 836-841
Peters, R.J.; Tortolero, S.R.; Addy, R.C.; Markham, C.; Yacoubian, G.S.; Escobar-Chaves, L.S. 2003: Drug use among Texas alternative school students: findings from Houston's Safer Choices 2 Program. Journal of Psychoactive Drugs 35(3): 383-387
Abdulkarim, A.A.; Mokuolu, O.A.; Adeniyi, A. 2005: Drug use among adolescents in Ilorin, Nigeria. Tropical Doctor 35(4): 225-228
Schirm, E.; Pedersen, L.; Tobi, H.; Nielsen, G.L.; Sørensen, H.T.; de Jong-van den Berg, L.T.W. 2004: Drug use among fathers around time of conception: two register based surveys from Denmark and The Netherlands. Pharmacoepidemiology and Drug Safety 13(9): 609-613
Passare, G.; Fastbom, J.; Törring, O.; Viitanen, M. 2004: Drug use and increased HbA1c levels in non-diabetic very elderly persons: the Kungsholmen project. European Journal of Clinical Pharmacology 60(2): 121-126
Piccoli, G.B.; Soragna, G.; Putaggio, S.; Consiglio, V.; Mezza, E.; Bonetto, A.; Geuna, S. 2006: Drug use and kidney donation: what are high-risk behaviors today?. Transplantation Proceedings 38(5): 1221-1223
Stephen, B., J.; Linsenmeyer, S., M.; Mcguire, S., M. 2005: Drug use and lifestyle at a Nebraska two-year college. Transactions of the Nebraska Academy of Sciences 30: 69-74
Liu, C.; Li, J.-Heng; Tsay, W.-Ing; Hsu, J. 2005: Drug use and profile of individuals arrested on drug-related charges in Taiwan. Journal of Food and Drug Analysis 13(2): 101-106
Benotsch, E.G.; Somlai, A.M.; Pinkerton, S.D.; Kelly, J.A.; Ostrovski, D.; Gore-Felton, C.; Kozlov, A.P. 2004: Drug use and sexual risk behaviours among female Russian IDUs who exchange sex for money or drugs. International Journal of Std and Aids 15(5): 343-347
Smink, B.E.; Ruiter, B.; Lusthof, K.J.; de Gier, J.J.; Uges, D.R.A.; Egberts, A.C.G. 2005: Drug use and the severity of a traffic accident. Accident; Analysis and Prevention 37(3): 427-433
Pilotto, A.; Franceschi, M.; Vitale, D.; Zaninelli, A.; Masotti, G.; Rengo, F. 2006: Drug use by the elderly in general practice: effects on upper gastrointestinal symptoms. European Journal of Clinical Pharmacology 62(1): 65-73
Peretti-Watel, P.; Spire, B.; Lert, F.; Obadia, Y. 2006: Drug use patterns and adherence to treatment among HIV-positive patients: evidence from a large sample of French outpatients (ANRS-EN12-VESPA 2003). Drug and Alcohol Dependence 82(Suppl): S71-S79
Hach, I.; Rentsch, A.; Ruhl, U.E.; Becker, E.S.; Türke, V.; Margraf, Jürgen.; Kirch, W. 2004: Drug use patterns in young German women and association with mental disorders. Annals of PharmacoTherapy 38(9): 1529-1534
Carlson, R.G.; Wang, J.; Falck, R.S.; Siegal, H.A. 2005: Drug use practices among MDMA/ecstasy users in Ohio: a latent class analysis. Drug and Alcohol Dependence 79(2): 167-179
Inchaurraga, S. 2003: Drug use, harm reduction, and health policies in Argentina: obstacles and new perspectives. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 37(Suppl 5): S366-S371
Liu, H.; Grusky, O.; Li, X.; Ma, E. 2006: Drug users: a potentially important bridge population in the transmission of sexually transmitted diseases, including AIDS, in China. Sexually Transmitted Diseases 33(2): 111-117
Tobi, H.; Scheers, T.; Netjes, K.A.; Mulder, E.J.; de Bildt, A.; Minderaa, R.B. 2005: Drug utilisation by children and adolescents with mental retardation: a population study. European Journal of Clinical Pharmacology 61(4): 297-302
Sanz, E.; Hernández, M.A.; Ratchina, S.; Stratchounsky, L.; Peiré, M.A.; Lapeyre-Mestre, M.; Horen, B.; Kriska, M.; Krajnakova, H.; Momcheva, H.; Encheva, D.; Martínez-Mir, I.; Palop, V. 2004: Drug utilisation in outpatient children. a comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia). European Journal of Clinical Pharmacology 60(2): 127-134
Ay, P.; Akici, A.; Harmanc, H. 2005: Drug utilization and potentially inappropriate drug use in elderly residents of a community in Istanbul, Turkey. International Journal of Clinical Pharmacology and Therapeutics 43(4): 195-202
Zuppa, A.F.; Adamson, P.C.; Mondick, J.T.; Davis, L.A.; Maka, D.A.; Narayan, M.; Nicholson, C.; Patel, D.; Collison, K.R.; Barrett, J.S. 2005: Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children. Journal of Clinical Pharmacology 45(11): 1305-1312
Biswal, S.; Mishra, P.; Malhotra, S.; Puri, G.D.; Pandhi, P. 2006: Drug utilization pattern in the intensive care unit of a tertiary care hospital. Journal of Clinical Pharmacology 46(8): 945-951
Chen, L.C.; Wang, B.R.; Chou, Y.C.; Tien, J.H. 2005: Drug utilization pattern of Chinese herbal medicines in a general hospital in Taiwan. Pharmacoepidemiology and Drug Safety 14(9): 651-657
Mohanty, M.; Mohapatra, S. 2003: Drug utilization pattern of topical ocular antimicrobials in a tertiary care hospital. Indian Journal of Pharmacology 35(6): 399
Pulver, L.K.; Tett, S.E. 2006: Drug utilization review across jurisdictions--a reality or still a distant dream?. European Journal of Clinical Pharmacology 62(2): 97-106
LeLorier, J.; Fitzsimon, C.; Keresteci, M.; Stewart, D.; Lavoie, F. 2003: Drug utilization review of celecoxib in Ontario. Rheumatology 42(Suppl 3): Iii11-Iii16
Luo, N.; Koh, Y.; Tan, C.H.; Kua, E.H.; Li, S.C. 2004: Drug utilization review of risperidone for outpatients in a tertiary referral hospital in Singapore. Human Psychopharmacology 19(4): 259-264
Hallas, J. 2005: Drug utilization statistics for individual-level pharmacy dispensing data. Pharmacoepidemiology and Drug Safety 14(7): 455-463
Daneshtalab, N.; Lewanczuk, R.Z.; Russell, A.S.; Jamali, F. 2006: Drug-disease interactions: losartan effect is not downregulated by rheumatoid arthritis. Journal of Clinical Pharmacology 46(11): 1344-1355
Kearney, B.P.; Sayre, J.R.; Flaherty, J.F.; Chen, S.-S.; Kaul, S.; Cheng, A.K. 2005: Drug-drug and drug-food interactions between tenofovir disoproxil fumarate and didanosine. Journal of Clinical Pharmacology 45(12): 1360-1367
Rheeders, M.; Bouwer, Mène.; Goosen, T.C. 2006: Drug-drug interaction after single oral doses of the furanocoumarin methoxsalen and cyclosporine. Journal of Clinical Pharmacology 46(7): 768-775
Kenawi, I.M.; Barsoum, B.N.; Youssef, M.A. 2005: Drug-drug interaction between diclofenac, cetirizine and ranitidine. Journal of Pharmaceutical and Biomedical Analysis 37(4): 655-661
Hirano, M.; Maeda, K.; Shitara, Y.; Sugiyama, Y. 2006: Drug-drug interaction between pitavastatin and various drugs via OATP1B1. Drug Metabolism and Disposition: the Biological Fate of Chemicals 34(7): 1229-1236
Niwa, T.; Shiraga, T.; Takagi, A. 2005: Drug-drug interaction of antifungal drugs. Yakugaku Zasshi: Journal of the Pharmaceutical Society of Japan 125(10): 795-805
Sitsen, J.; Maris, F.; Timmer, C. 2001: Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects. European Journal of Drug Metabolism and Pharmacokinetics 26(1-2): 109-121
Glintborg, B.; Andersen, S.Ejdrup.; Dalhoff, K. 2005: Drug-drug interactions among recently hospitalised patients--frequent but mostly clinically insignificant. European Journal of Clinical Pharmacology 61(9): 675-681
Yoshiyama, Y.; Sugiyama, T.; Kanke, M.; Tsuchimoto, K. 2004: Drug-drug interactions between antiarrhythmic drugs in chick embryos. Biological and Pharmaceutical Bulletin 27(1): 128-130
Williams, J.A.; Hyland, R.; Jones, B.C.; Smith, D.A.; Hurst, S.; Goosen, T.C.; Peterkin, V.; Koup, J.R.; Ball, S.E. 2004: Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi/AUC) ratios. Drug Metabolism and Disposition: the Biological Fate of Chemicals 32(11): 1201-1208
Furuta, S.; Kamada, E.; Omata, T.; Sugimoto, T.; Kawabata, Y.; Yonezawa, K.; Wu, X.C.; Kurimoto, T. 2004: Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338. European Journal of Pharmacology 497(2): 223-231
Fridén, M.; Vanaja, K.; Nandi, V.N. 2006: Drug-drug interactions of anti-infective drugs: utility of fluorescence cyp inhibition assays in drug discovery. Drug Metabolism and Drug Interactions 21(3-4): 163-185
Huang, S-Mei.; Lesko, L.J. 2004: Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?. Journal of Clinical Pharmacology 44(6): 559-569
Cosgrave, J.; Melzi, G.; Biondi-Zoccai, G.G.L.; Airoldi, F.; Chieffo, A.; Sangiorgi, G.M.; Montorfano, M.; Michev, I.; Carlino, M.; Bonizzoni, E.; Colombo, A. 2006: Drug-eluting stent restenosis the pattern predicts the outcome. Journal of the American College of Cardiology 47(12): 2399-2404
Moreno, R.úl.; Fernández, C.; Hernández, R.; Alfonso, F.; Angiolillo, D.J.; Sabaté, M.; Escaned, J.; Bañuelos, C.; Fernández-Ortiz, A.; Macaya, C. 2005: Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. Journal of the American College of Cardiology 45(6): 954-959
Kaneda, H. 2006: Drug-eluting stent thrombosis: a pooled analysis. Journal of the American College of Cardiology 47(1): 214; Author Reply 214-5
Leon, M.B.; Bakhai, A. 2003: Drug-eluting stents and glycoprotein IIb/IIIa inhibitors: combination therapy for the future. American Heart Journal 146(4 Suppl): S13-S17
Pache, Jürgen.; Dibra, A.; Mehilli, J.; Dirschinger, J.; Schömig, A.; Kastrati, A. 2005: Drug-eluting stents compared with thin-strut bare stents for the reduction of restenosis: a prospective, randomized trial. European Heart Journal 26(13): 1262-1268
Finn, A.V.; Palacios, I.F.; Kastrati, A.; Gold, H.K. 2005: Drug-eluting stents for diabetes mellitus: a rush to judgment?. Journal of the American College of Cardiology 45(4): 479-483
Schofer, J.; Bode, C.; Silber, S. 2004: Drug-eluting stents for in-stent restenosis and acute myocardial infarction: present data from nonrandomized studies. Herz 29(2): 195-200
Abou-Chebl, A.; Bashir, Q.; Yadav, J.S. 2005: Drug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-up. Stroke 36(12): E165-E168
Moses, J.W.; Stone, G.W.; Nikolsky, E.; Mintz, G.S.; Dangas, G.; Grube, E.; Ellis, S.G.; Lansky, A.J.; Weisz, G.; Fahy, M.; Na, Y.; Russell, M.E.; Donohoe, D.; Leon, M.B.; Mehran, R. 2006: Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials. Journal of the American College of Cardiology 47(11): 2164-2171
Pires, N.M.M.; Jukema, J.W.; Daemen, M.J.A.P.; Quax, P.H.A. 2006: Drug-eluting stents studies in mice: do we need atherosclerosis to study restenosis?. Vascular Pharmacology 44(5): 257-264
Dobesh, P.P.; Stacy, Z.A.; Ansara, A.J.; Enders, J.M. 2004: Drug-eluting stents: a mechanical and pharmacologic approach to coronary artery disease. PharmacoTherapy 24(11): 1554-1577
Bhatia, V.; Bhatia, R.; Dhindsa, M. 2004: Drug-eluting stents: new era and new concerns. Postgraduate Medical Journal 80(939): 13-18
Parry, T.J.; Brosius, R.; Thyagarajan, R.; Carter, D.; Argentieri, D.; Falotico, R.; Siekierka, J. 2005: Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteries. European Journal of Pharmacology 524(1-3): 19-29
Haery, C.; Sachar, R.; Ellis, S.G. 2004: Drug-eluting stents: the beginning of the end of restenosis?. Cleveland Clinic Journal of Medicine 71(10): 815-824
Wong, A.; Chan, C. 2004: Drug-eluting stents: the end of restenosis?. Annals of the Academy of Medicine Singapore 33(4): 423-431
Hill, R.A.; Dündar, Y.; Bakhai, A.; Dickson, R.; Walley, T. 2004: Drug-eluting stents: an early systematic review to inform policy. European Heart Journal 25(11): 902-919
Virmani, R.; Farb, A.; Guagliumi, G.; Kolodgie, F.D. 2004: Drug-eluting stents: caution and concerns for long-term outcome. Coronary Artery Disease 15(6): 313-318
Van der Hoeven, B.L.; Pires, N.M.M.; Warda, H.M.; Oemrawsingh, P.V.; van Vlijmen, B.J.M.; Quax, P.H.A.; Schalij, M.J.; van der Wall, E.E.; Jukema, J.W. 2005: Drug-eluting stents: results, promises and problems. International Journal of Cardiology 99(1): 9-17
Batista de Carvalho, L.A.E.; Marques, M.P.M.; Tomkinson, J. 2006: Drug-excipient interactions in ketoprofen: a vibrational spectroscopy study. Biopolymers 82(4): 420-424
Goullé, J-Pierre.; Anger, J-Pierre. 2004: Drug-facilitated robbery or sexual assault: problems associated with amnesia. Therapeutic Drug Monitoring 26(2): 206-210
Zhao, X.; You, T.; Liu, J.; Sun, X.; Yan, J.; Yang, X.; Wang, E. 2004: Drug-human serum albumin binding studied by capillary electrophoresis with electrochemiluminescence detection. Electrophoresis 25(20): 3422-3426
Ueno, Y.; Futagawa, H.; Takagi, Y.; Ueno, A.; Mizushima, Y. 2005: Drug-incorporating calcium carbonate nanoparticles for a new delivery system. Journal of Controlled Release: Official Journal of the Controlled Release Society 103(1): 93-98
Shah, R.R. 2005: Drug-induced QT dispersion: does it predict the risk of torsade de pointes?. Journal of Electrocardiology 38(1): 10-18
Shah, R.R. 2004: Drug-induced QT interval prolongation: regulatory perspectives and drug development. Annals of Medicine 36(Suppl): 47-52
Fenichel, R.R.; Malik, M.; Antzelevitch, C.; Sanguinetti, M.; Roden, D.M.; Priori, S.G.; Ruskin, J.N.; Lipicky, R.J.; Cantilena, L.R. 2004: Drug-induced torsades de pointes and implications for drug development. Journal of Cardiovascular Electrophysiology 15(4): 475-495
Tokutomi, N.; Tokutomi, Y.; Nishi, K. 2004: Drug-induced anomalous contraction of gastrointestinal tract of mice with impaired c-kit function. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 123(3): 163-169
Izawa, M.; Harada, T.; Deura, I.; Taniguchi, F.; Iwabe, T.; Terakawa, N. 2006: Drug-induced apoptosis was markedly attenuated in endometriotic stromal cells. Human Reproduction 21(3): 600-604
Zeltser, D.; Justo, D.; Halkin, A.; Rosso, R.; Ish-Shalom, M.; Hochenberg, M.; Viskin, S. 2004: Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. Journal of the American College of Cardiology 44(1): 105-108
Layland, L.E.; Wulferink, M.; Dierkes, S.; Gleichmann, E. 2004: Drug-induced autoantibody formation in mice: triggering by primed CD4+CD25- T cells, prevention by primed CD4+CD25+ T cells. European Journal of Immunology 34(1): 36-46
Calderone, V.; Testai, L.; Martinotti, E.; Del Tacca, M.; Breschi, M.C. 2005: Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics. Journal of Pharmacy and Pharmacology 57(2): 151-161
Gussak, I.; Litwin, J.; Kleiman, R.; Grisanti, S.; Morganroth, J. 2004: Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development. Journal of Electrocardiology 37(1): 19-24
Pichon, M.F.; Cvitkovic, F.; Hacene, K.; Delaunay, J.; Lokiec, F.; Collignon, M.A.; Pecking, A.P. 2005: Drug-induced cardiotoxicity studied by longitudinal B-type natriuretic peptide assays and radionuclide ventriculography. In Vivo 19(3): 567-576
Mauz-Körholz, C.; Kachel, M.; Harms-Schirra, B.; Klein-Vehne, A.; Tunn, P.-U.; Körholz, D. 2004: Drug-induced caspase-3 activation in a Ewing tumor cell line and primary Ewing tumor cells. Anticancer Research 24(1): 145-149
Duggal, H.S.; Singh, I. 2005: Drug-induced catatonia. Drugs of Today 41(9): 599-607
Fujiki, A.; Sakabe, M.; Nishida, K.; Sugao, M.; Tsuneda, T.; Iwamoto, J.; Mizumaki, K.; Inoue, H. 2004: Drug-induced changes in fibrillation cycle length and organization index can predict chemical cardioversion of long-lasting atrial fibrillation with bepridil alone or in combination with aprindine. Circulation Journal: Official Journal of the Japanese Circulation Society 68(12): 1139-1145
Gerecitano, J.; Goy, A.; Wright, J.; MacGregor-Cortelli, B.; Neylon, E.; Gonen, M.; Esseltine, D.; Boral, A.; Schenkein, D.; Busam, K.; Teruya-Feldstein, J.; Sachs, D.; O'Connor, O.A. 2006: Drug-induced cutaneous vasculitis in patients with non-Hodgkin lymphoma treated with the novel proteasome inhibitor bortezomib: a possible surrogate marker of response?. British Journal of Haematology 134(4): 391-398
Zaprudnov, A.M. 2003: Drug-induced damages to digestive organs in children. Rossiiskii Vestnik Perinatologii i Pediatrii 48(5): 24-29
Patten, S.B.; Barbui, C. 2004: Drug-induced depression: a systematic review to inform clinical practice. PsychoTherapy and Psychosomatics 73(4): 207-215
Tredwin, C.J.; Scully, C.; Bagan-Sebastian, J-V. 2005: Drug-induced disorders of teeth. Journal of Dental Research 84(7): 596-602
Yawalkar, N. 2005: Drug-induced exanthems. Toxicology 209(2): 131-134
Casetti, R.; Perretta, G.; Taglioni, A.; Mattei, M.; Colizzi, V.; Dieli, F.; D'Offizi, G.; Malkovsky, M.; Poccia, F. 2005: Drug-induced expansion and differentiation of V gamma 9V delta 2 T cells in vivo: the role of exogenous IL-2. Journal of Immunology 175(3): 1593-1598
Martinez, J.M.; Sali, T.; Okazaki, R.; Anna, C.; Hollingshead, M.; Hose, C.; Monks, A.; Walker, N.J.; Baek, S.J.; Eling, T.E. 2006: Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene/macrophage inhibitory cytokine-1/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth. Journal of Pharmacology and Experimental Therapeutics 318(2): 899-906
Hippius, M.; Hegenbart, U. 2005: Drug-induced gastrointestinal disorders in surgical patients admitted to the University Hospital, Jena, Germany. International Journal of Clinical Pharmacology and Therapeutics 43(8): 406-410
Tomiyasu, N.; Tsuruta, O.; Mitsuyama, K.; Et-Al 2005: Drug-induced hemorrhagic enterocolitis. Stomach and Intestine (Tokyo) 40(4): 611-615
Tokumoto, Y.; Horiike, N.; Onji, M.; Ueda, T.; Kumagi, T.; Abe, M.; Michitaka, K. 2003: Drug-induced hepatitis due to repeated use of hair dye. Internal Medicine 42(11): 1104-1106
Grubisić-Cabo, F.; Vrdoljak, E. 2006: Drug-induced hepatitis in a patient with malignant melanoma treated with interferon alfa 2b adjuvantly who had been administered gemfibrozil in therapy. Medical Oncology 23(1): 121-124
Feenstra, J.; van Aken, M.O.; de Herder, W.W.; Feelders, R.A.; van der Lely, A.J. 2006: Drug-induced hepatitis in an acromegalic patient during combined treatment with pegvisomant and octreotide long-acting repeatable attributed to the use of pegvisomant. European Journal of Endocrinology 154(6): 805-806
Araujo, N.P.; Fukushiro, D.F.; Cunha, J.L.S.; Levin, R.; Chinen, C.C.; Carvalho, R.C.; Ribeiro, I.C.P.; Gomes, D.C.; Abílio, V.C.; Silva, R.H.; Ribeiro, R.d.A.; Frussa-Filho, R. 2006: Drug-induced home cage conspecifics' behavior can potentiate behavioral sensitization in mice. Pharmacology Biochemistry and Behavior 84(1): 142-147
Bandyopadhyay, P. 2006: Drug-induced hyperprolactinemia. Timely Topics in Medicine. Cardiovascular Diseases 10: E14
Nakashima, H.; Yamane, K.; Ihn, H.; Nakamura, K.; Watanabe, R.; Kuwano, Y.; Takekoshi, T.; Watanabe, T.; Hattori, N.; Fujimoto, M.; Tamaki, K. 2005: Drug-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and increase in serum IgE level. Dermatology 210(4): 349-352
Hara, H.; Kobayashi, M.; Yokoyama, A.; Tochigi, M.; Matsunaga, A.; Shimizu, H.; Goshima, J.; Suzuki, H. 2005: Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7. Dermatology 211(2): 159-161
Mitani, N.; Aihara, M.; Yamakawa, Y.; Yamada, M.; Itoh, N.; Mizuki, N.; Ikezawa, Z. 2005: Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses. Journal of Medical Virology 75(3): 430-434
Gaasbeek, D.; Naarding, P.; Stor, T.; Kremer, H.P.H. 2004: Drug-induced hyperthermia in Huntington's disease. Journal of Neurology 251(4): 454-457
Aster, R.H. 2005: Drug-induced immune cytopenias. Toxicology 209(2): 149-153
Aquino, A.; Formica, V.; Prete, S.P.; Correale, P.P.; Massara, M.C.; Turriziani, M.; De Vecchis, L.; Bonmassar, E. 2004: Drug-induced increase of carcinoembryonic antigen expression in cancer cells. Pharmacological Research 49(5): 383-396
Kamal, M.A.; French, S.W. 2004: Drug-induced increased mitochondrial biogenesis in a liver biopsy. Experimental and Molecular Pathology 77(3): 201-204
Arakawa, M.; Murata, Y.; Rikimaru, Y.; Sasaki, Y. 2005: Drug-induced isolated visceral angioneurotic edema. Internal Medicine 44(9): 975-978
Juurlink, D.N.; Mamdani, M.M.; Kopp, A.; Rochon, P.A.; Shulman, K.I.; Redelmeier, D.A. 2004: Drug-induced lithium toxicity in the elderly: a population-based study. Journal of the American Geriatrics Society 52(5): 794-798
Sulkowski, M.S. 2004: Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 38(Suppl 2): S90-S97
Dieterich, D.T.; Robinson, P.A.; Love, J.; Stern, J.O. 2004: Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 38(Suppl 2): S80-S89
Andrade, Rúl.J.; Lucena, M.Isabel.; Fernández, M.Carmen.; Pelaez, G.; Pachkoria, K.; García-Ruiz, E.; García-Muñoz, B.; González-Grande, R.; Pizarro, A.; Durán, Jé.Antonio.; Jiménez, M.; Rodrigo, L.; Romero-Gomez, M.; Navarro, Jé.María.; Planas, Rón.; Costa, J.; Borras, A.; Soler, A.; Salmerón, J.; Martin-Vivaldi, R. 2005: Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129(2): 512-521